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Abstract 
Biotin is a commercially important vitamin which acts as a cofactor in 
enzymatic carboxylation reactions. Biotin biosynthesis occurs by similar 
pathways in both microorganisms and plants. 
This thesis describes studies on the last two enzymes on the biotin 
biosynthetic pathway. The penultimate enzyme, dethiobiotin synthetase 
(DTBS), catalyses the ureido ring closure of dethiobiotin from (7R,8S)-7,8-
diaminononanoate (DAPA), carbon dioxide and ATP. The final step, 
catalysed by biotin synthase, involves the chemically difficult insertion of 
sulphur into the unactivated carbon skeleton of dethiobiotin to yield 
biotin. 
A range of analogues of DAPA differing in chain length and C-8 
substitution were synthesised and found to act as slow substrates of 
DTBS. Steady-state kinetic and binding parameters were evaluated for 
these modified substrates and their relevance to the mechanism of the 
DTBS reaction is discussed. Crystallographic and modelling studies of 
one analogue bound in the active site of DTBS suggests that the enzyme 
may employ an alternative mechanism of ureido ring closure to that of 
the native substrate. 
Biotin production was demonstrated in cell-free extracts of an E.coli bioB 
transformant and the origin of the sulphur atom in biotin was 
investigated. A novel cysteine desulphurase enzyme, which catalyses the 
desulphurisation of L-cysteine to give L-alanine and sulphur, was 
discovered and its possible role in the biotin synthase reaction is 
discussed. 
[6, 62H2] - (±)-dethiobiotin and [6,6-F2] -(±)-dethiobiotin were identified as 
target compounds in intermediate trapping experiments and as selective 
biocides. A synthetic route to these compounds was devised and the 
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Abbreviations 
a.a amino acid 
AdoMet S-adenosylmethionine 
ADP adenosine diphosphate 
Amp ampicillin 
anaRNR anaerobic ribonucleotide reductase 
AOP 8-amino-7-oxopelargonic acid 
aq. aqueous 
ATP adenosine triphosphate 
ATPase adenosine 	triphosphatase 
BCP biotin carrier protein 
b.p boiling point 
hr broad 
BSA bovine serum albumin 
cm centimetere(s) 
CoA coenzyme A 
d doublet 
DAPA 7,8-diaminopelargonic acid 
'C NMR chemical shifts 
'H NMR chemical shifts 
DTB dethiobiotin 
DTBS dethiobiotin synthetase 
DTT dithiothreitol 
EDTA ethylenediamine tetraacetic acid 
FABMS fast atom bombardment mass spectrometry 
FAD flavin adenine dinucleotide (oxidised form) 
FADH2 flavin adenine dinucleotide (reduced form) 
FPLC fast protein liquid chromatography 
Vi 
FTIR 	 fourier transform infrared (spectroscopy) 
g grams 
hplc high pressure liquid chromatography 
HYPE high voltage paper electrophoresis 
IPTG isopropyl 	-D-thioga1actoside 
J spin-spin coupling constant 











m.p melting point 
MS mass spectrometry 
m/z mass to charge ratio 
NAD nicotinamide adenine dinucleotide (oxidised 
form) 
NADH nicotinamide adenine dinucleotide (reduced 
form) 
NADP nicotinamide adenine dinucleotide phosphate 
(oxidised form) 
NADPH nicotinamide adenine dinucleotide phosphate 
(reduced form) 
nm nanometre 
NMR nuclear magnetic resonance 
0D280,600 optical density at 280nm or GOOnm 
VII 
ppm 	 parts per million 
Pi 	 inorganic orthophosphate 
PP1 	 inorganic pyrophosphate 
q 	 quartet 
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1.1 Biotin and its role in mammalian biochemistry 
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Our understanding of the metabolism of biotin 1 has accumulated 
intermittently since its discovery, at the turn of the century, as a result of 
the effects of nutritional deficiency. It was not until 1936 that the 
compound was first obtained in crystalline form from egg yolk by Kogl 
and Tönnis'. It required an additional seven years for the elucidation of 
its structure by du Vigneaud et al.2-5 and a further two years to synthesise 
the vitamin6'7. Over a decade elapsed before Wakil et al.8 discovered that 
biotin was an integral part of the acetyl CoA carboxylase enzyme, 
indicating a cofactorial role for biotin in carboxylation reactions in 
metabolism. 
There are four biotin-dependent carboxylases important in human 
biochemistry9 (Fig.1.1). 	13-Methyl crotonyl CoA carboxylase and 
propionyl CoA carboxylase are involved in amino acid metabolism, acetyl 
CoA carboxylase is a key enzyme in fatty acid biosynthesis and pyruvate 
carboxylase is the primary enzyme in gluconeo genesis. Because of the 
endogenous production of biotin by the intestinal flora, deficiency does 
not normally occur in man or higher animals, even when a biotin-free diet 
is administered. Biotin deficiency can be induced through large ingestion 
of raw egg white or by long-term antibiotic therapy. Symptoms suffered 
include dermatitis, alopecia, progressive ataxia and metabolic acidosis 
(see Fig.1.2). However, administration of supplemental biotin usually 
provides a quick and dramatic response to these ailments'° (Fig. 1.3). 
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Fig. 1.1 The role of biotin in cellular metabolism 
Fig.1.2 Two-year old child suffering 	Fig.1.3 Same child after six months of 
from biotin deficiency 	 daily biotin supplements 
1.2 Biotin-Avidin Biotechnology 
Since (+)-biotin is present in only minute amounts in biological tissues, 
the first total synthesis of biotin6 provided a stepping stone towards more 
detailed studies on its biological role in the cell. However, despite a 
plethora" of novel enantioselective syntheses of biotin in the literature 
there exists only one which has been successfully employed in the 
commercial preparation of the vitamin12. The increasing demand for this 
vitamin has come, not only from its value in mammalian nutrition but its 
role as a powerful biochemical tool through the highly specific binding of 
biotin to the egg white protein avidin or the analogous bacterial protein 
streptavidin (from Streptomyces avidinii). 
Avidin is a tetramer of four essentially identical subunits of 15 kDa each. 
X-ray crystal structural data13,14  has revealed that each monomer is an 
eight-stranded antiparallel 3-barrel, similar to that of the bacterial 
analogue streptavidin. The biotin binding site is located deep in the 
centre of the barrel where the presence of both hydrophobic and polar 
residues are required for its recognition. Avidin has four tryptophan 
residues per subunit and fluorescence studjes15 indicate that the binding 
of biotin shifts two or three tryptophans to an internal, hydrophobic, 
shielded environment and that the bound biotin is completely buried 
within the protein core. The high affinity ( Ki = 10-15M) for biotin is 
undisturbed by extremes of pH, salts or chaotrophic agents and this 
strong interaction, together with the facile modification of biotin's 
carboxylate functional group allowing the construction of a wide range of 
conjugates, has provided researchers with a unique tool for use in 
receptor studies, immunocytochemical staining and protein isolation16. 
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1.3 The Biological Role of Biotin 
Evidence supporting the role of biotin in the biosystem began with the 
isolation of biocytin 2 from yeast and the proposal that biotin existed 
covalently linked to a lysine residue of biotin-dependent enzymes17. 
Kasow and Lane verified this linkage of biotin to its carrier protein in the 
enzyme propionyl CoA carboxylase18 and this manner of coupling has 
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Biotin has now been shown to have a definitive cofactorial role for a group 
of carboxylases that can be subdivided into three classes. 
In Class I (carboxylase) enzymes, biotin serves as a covalently bound 
"CO2 carrier" for reactions in which CO2 is fixed into acceptors such as 
pyruvate, acetyl-CoA, 13-methyl-crotonyl-CoA and urea. The ATP-
dependent carboxylation and subsequent transfer are summarized in the 
two partial reactions shown below: 
Mg 2 
Enz-biotin + ATP + HCO3 - 	Enz-biotin-0O2 + ADP + P + H 
Enz-biotin-0O2 + R-H 	- 	Enz-biotin + R-0O2 
The Class II (decarboxylase) enzymes catalyse the decarboxylation of 
13-keto acids and their thioesters and are responsible for regulation of 
sodium transport in anaerobes. Substrates for these enzymes include 
oxaloacetate, methylmalonyl-CoA and glutaconyl-CoA. 
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This class of enzymes serve as important energy transducers that do not 
require ATP and their reactions can be summarised as follows: 
Enz-biotin + R-0O2 	- 	Enz-biotin-0O2 + R-H 
Enz-biotin-0O2 + 2(Na). 	 Enz-biotin + HCO3 + 2(Na) 
out 
3) The one Class III enzyme identified, transcarboxylase (EC 2.1.3.1), 
plays a key role in the fermentation process in Propionibacterium 
shermanii and involves the following transcarboxylation: 
Enz-biotin + oxalacetate - 	Enz-biotin-0O2 + pyruvate 
Enz-biotin-0O2 + propionyl CoA - 	Enz-biotin + methylmalonyl CoA 
1.4 Mechanism of Carboxylation 
The structural data108  obtained from X-ray analysis of (+)-biotin provided 
an early insight into its mechanism of carboxylation. Since the distance 
between N-3' and C-6 of biotin is only 0.28nm, this steric hindrance from 
the valeric acid side chain suggested that carboxylation of biotin involved 
reversible formation of a N-i' carboxybiotin intermediate. 
The isolation and characterisation of the methyl ester of N-i' 
carboxybiotin by Lynen et al.20 suggested the enzymic intermediate in l-
methyl crotonyl CoA carboxylase was N-i' carboxybiotin. Bruice et al.2' 
suggested this structural assigment was equivocal and suggested an 
intermediary role for 0-carboxybiotin which rearranged to the more 
stable N-acyl material during methylation and isolation. However, the 
synthesis of authentic N-i carboxybiotinol22 and the demonstration of its 
ability to act as a competent substrate for the biotin carboxylase and 
carboxytransferase sub-units of E.coli acetyl CoA carboxylase provided 
convincing evidence that N-i carboxybiotin must be a true biochemical 
intermediate. 
Early 180  tracer studies by Kaziro et al.23 using [180]  bicarbonate as a 
substrate for propionyl CoA carboxylase demonstrated that two 180  atoms 
from HC1803- ended up in the carboxyl group of malonyl CoA and that the 
third was found in the phosphate derived from ATP. Three pathways for 
the mechanism of carboxylation have emerged, all consistent with the 
above observations (see Scheme Li) 
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Pathway A involves activation of bicarbonate by ATP to produce 
carboxyphosp hate. This activated bicarbonate (or CO2 derived from it) 
then carboxylates the N-i of biotin24. Pathway B25,26  involves the 
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formation of 0-phosphobiotin. This isoimide intermediate reacts with 
bicarbonate to give the carboxylated biotin and phosphate. The third 
pathway C27 also utilises 0-phosphobiotin as an intermediate, but this is 
then attacked by bicarbonate to carboxyphosphate and the ureido anion 
of biotin which in turn react to carboxylate biotin. 
Discriminating between these proposed pathways has proved difficult 
since isotope exchange in partial reactions of several biotin-dependent 
carboxylases24'28 and intermediate trapping29'30 have proved unsuccessful. 
However, stereochemical experiments have provided evidence towards 
the exclusion of certain mechanisms. 
Knowles et al.31 synthesised the [y-170,7-180]-y-phosphorothioate of ATP 
and utilised this chiral substrate to examine the stereochemical fate of 
the y-phosphogroup of ATP in the reaction catalysed by pyruvate 
carboxylase. This experiment relied on the fact that enzyme-catalysed 
phospho group transfer involves inversion of configuration at 
phosphorus32. Therefore pathway A and B are expected to proceed with 
inversion of configuration whereas pathway C proceeds with net 
retention. They have argued that pseudorotatory effects (upon formation 
of 0-phosphobiotin) were not applicable due to lack of enzymic precedent. 
Determination of the [160, 1 0, 180]-thiophosphate chirality resulted in 
overall inversion of configuration and this effectively rules out pathway 
C. 
Concern regarding the low nuleophilicity of biotin's N-i has been 
partially resolved. The proposed33 high energy dianionic tetrahedral 
intermediate that would result from nucleophiic attack upon 
carboxyphosphate can be avoided through prior dissociation to the more 
electrophilic carbon dioxide and P1. Although the failure to detect 
ATP/solvent oxygen exchange in positional isotope exchange 
experiments30 does not discount carbon dioxide as the carboxylating 
7 
species, the inability to trap the carboxyphosphate intermediate may 
suggest high reactivity or subsequent dissociation at the active site. 
However, the ability of biotin carboxylase to synthesise ATP by utilising 
carbamoyl phosphate as a substrate34 and its bicarbonate-dependent 
ATPase activity strengthen the view that carboxylation of biotin may 
proceed through pathway A. 
1.5 Mechanism of Carboxyl Transfer 
The early experiments of Retey and Lynen35 on propionyl CoA 
carboxylase provided evidence on the stereochemistry and proton 
exchange involved in the enzymic reaction. They established that the 
reaction proceeds with retention of configuration at the site of 
carboxylation and that the exchange of protons between solvent and 
substrate was only accompanied with overall turnover. These early 
experiments led to a variety of proposals35'36 involving either a concerted 
process 1, or stepwise mechanisms such as 2 and 3 as shown in Scheme 
1.2. 
Resolution of these proposals was obtained by Stubbe et al.37 who 
examined the action of propionyl CoA carboxylase on f3-fluoropropionyl 
CoA. They observed a 6-fold increase in fluoride release compared to 
ADP formation and no evidence for the production of 
fluoromethylmalonyl CoA. The release of fluoride ion is indicative of a-
proton abstraction from the substrate and the formation of ADP 
corresponds to the accumulation of biotin-0O2. These results indicated 
that hydrogen abstraction could occur without concomitant CO2 transfer 
from carboxylated biotin to the substrate. Thus the concerted mechanism 
1 is not applicable and the authors suggested that the non-concerted 
8 
process should occur with "normal" substrates and that there must be a 

















This mechanistic issue was settled by Knowles et al.38 who employed 
double isotope fractionation to evaluate the rate-determining steps in 
transcarboxylase. Although both [13C]-pyruvate and [2H3]-pyruvate gave 
primary isotope effects which didn't rule out either mechanism, the 
correct mechanism was distinguished by examining the consequence of 
substrate deuteration on the 'C isotope effect. The 13C effect with protio-
substrate (2.3%) fell significantly on administration of deuterio-substrate 
(1.4%) indicating the carboxylation is a stepwise process which effectively 
rules out the concerted pathway 1. 
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1.6 The Biotin Operon 
The enzymes of biotin synthesis in E.coli are encoded by the bio operon 
which is located at 17 min on the genetic map39 between the attachment 
site of the lambda prophage (att?) and the uvrB gene. Complementation 
analysis by Rolfe40 and Cleary and Campbell4' indicated that the operon 
contained 5 complementation groups, namely bioA, bioB, bioC, bioD and 
bioF. An unlinked gene, bioH, has also been discovered42 along with bioP, 










Fig.1.3. Chromosomal locations of the E.coli No genes (minutes) 
Cleary et al.44 and Adhya et al.45 established the gene order of the operon 
using deletion mapping and after determining the gene activity of 
deletion mutants concluded that the operon was divergently transcribed: 
bioB, F, C and bioD being transcribed as a unit from left to right and bioA 
from right to left, from a promoter/operator region located between bioA 
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bioA gene product - DAPA aminotransferase (430 a.a, 47,403 Da) 
bioB gene product - Biotin synthase (346 a.a, 38,665 Da) 
bioF gene product - KAPA synthetase (384 a.a, 41,599 Da) 
bioC gene product - Unknown (prior to pimeloyl CoA, 251 a.a, 28,322 Da) 
bioD gene product - Dethiobiotin synthetase (218 a.a, 23,917 Da) 
ORF 1- Open Reading Frame (158 a.a, 17,101 Da) 
Fig.1.4. The bio operon of Escherichia coli 
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1.7 Regulation of the bio operon 
The earliest evidence for the control of biotin biosynthesis was discovered 
when Pai and Lichstein46 noted that the total cellular biotin 
concentration decreased with increased biotin concentration in the 
growth media. The nature of this inhibition was shown to be repression 
rather than feedback inhibition. Eisenberg et al.47 examined the 
interaction of the biorepressor with the operator site and concluded that 
the repressor protein is the product of the birA (bioR) gene, a 35.3 kDa 
protein now known as biotin holoenzyme synthetase. This bifunctional 
protein serves as both the biotin 	activating enzyme and the 
transcriptional regulator for the bio operon. The birA protein can 
activate biotin in the presence of ATP to form biotinyl-AMP, the co-
repressor, which remains tightly bound to the repressor protein. This 
complex can either bind to the operator site and inhibit transcription or 
transfer the biotinyl moeity to a lysine residue on the apoenzyme of the 
biotin carboxyl carrier protein (BBCP) subunit of acetyl CoA carboxylase. 
In summary, the birA gene product can catalyse each of the three 
reactions shown below: 
Biotin + ATP + birAGP 	biotinyl-5'-AMP-birAGP + PPi 
Biotinyl-5'-AMP-birAGP + apoenzyme 	holoenzyme + AMP + birAGP 
Biotinyl-5'-AMP-birAGP + operator 	> biotinyl-5'-AMP-birAGP-operator 
Thus the birA gene product synthesises its own co-repressor which is 
unique property among DNA binding proteins. The three dimensional 
crystal structure of the repressor protein displays three domains 
including a helix-loop-helix DNA binding motif48. Consequently the level 
of expression of the biosynthetic enzymes and the amount of biotin 
synthesised de novo is dependant on the intracellular biotin concentration 
12 
and on the concentration of unbiotinylated carrier protein to which biotin 
must be attached to fulfill its essential metabolic role (see Fig.1.5) 
1.8 The Biosynthesis of Biotin 
The nature of the biosynthetic and degradation pathways of biotin has 
preceded our knowledge of its mode of action. The miniscule quantities 
required to maintain normal cell function and therefore the limited 
amounts of possible metabolic intermediates available present a 
relatively unattractive target for biosynthetic studies. However, detailed 
investigation into the biogenesis of biotin has clarified the essentials of 
its biosynthetic construction. 
Early bacterial studies by Mue11er495' and du Vigneaud52 provided the 
first insights into the biosynthesis of biotin. The requirement of pimelic 
acid 8 and biotin 2 as a growth factor for Corynebacterium diphtheriae 
and the discovery53 that dethiobiotin was as effective as biotin in 
supporting the growth of Saccharomyces cerevisiae led to the use of 
radiotracer methods, substrate analogues and genetic mutants to 
interpret the major steps in the biosynthesis of the coenzyme. On the 
basis of their results and those of other workers, studies with Escherichia 
coli mutants prompted Eisenberg et al.54 to propose the pathway for 
biotin biosynthesis given in Scheme 1.3. 
This route proceeds by condensation of L-alanine 5 with pimeloyl CoA 4 
to give 7-keto-8-aminopelargonic acid (7-KAPA) 6. Transamination then 
leads to 7,8-diaminopelargonic acid (DA-PA) 7. DAPA subsequently reacts 
with carbon dioxide in the presence of ATP to generate dethiobiotin 8. 
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Fig.1.5 Regulation of the biotin operon 
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Scheme 1.3. Biosynthesis of Biotin 
Initial tracer studies by both Eisenberg55 and Elford and Wright56 
established the precursorial role of pimelic acid. Both performed feeding 
experiments with [1,7-'4C] pimelic acid and isolated the labelled 
metabolites, biotin and dethiobiotin from Phycomyces blakesleeanus and 
biotin-1-sulphoxide from Aspergillus niger. However the origin of pimelic 
acid is still unclear. Lynen et al.57 proposed, based on early labelling 
studies with 14CO2 in Achromobacter, that the biosynthetically aberrant 
15 
C-7 dicarboxylic acid derived pimelate group of biotin was constructed 
from three malonate units, the starter unit retaining the CO2 derived 
carboxylate which became the C-9 of biotin. 
Malonyl units have been shown to act as starter groups in other 
pathways, such as the biosynthesis of tetracycline58. However, in his 
experiment, Lynen could not locate 40% of the label incorporated and 
consequently the data does not exclude other biosynthetic routes 
including C2 degradation of a higher homologue or C2 addition to a lower 
homologue. Higher homologues of pimelic acid, have been shown to 
stimulate biotin production but this has been attributed to oxidation58a) 
Ogata59 found that of several odd numbered chain dicarboxylic acids, only 
glutaric acid appeared to be essential for biotin biosynthesis in strains of 
Agrobacterium radio bacter whilst pimelic acid was inactive. Although 
.the investigators mooted the possibility of a new biosynthetic pathway to 
biotin, it cannot be ruled out that the organism can activate glutaric but 
not pimelic acid to the CoA derivative and subsequently add a C2 unit. 
Two recent investigations60'6' into the origin of carbon atoms from biotin 
have shed new light on the ambiguous of role of pimelic acid. Feeding 
experiments in E.coli by Ifuku et al.6' and Sanyal et al.60 with [1-'3C]- 
acetate and [2-'3C]-acetate suggest that the formation of pimeloyl CoA 




2 x 0 
	 o 0 	 a 0 0 
+ 
1 OH HO 0 OH HO 0 	1 TE HO 




HO' '14TE > HO'i'*' TE 2 1  
0 	 0 
HOA -> - -p - 
HN' 'NH 
HO4%?'2 T3 
Scheme 1.4 . Proposed modified fatty acid synthesis pathway for formation of 
pimeloyl-CoA in E.coli. The darker bonds indicate intact acetate units. Three 
arrows in a row indicates reduction, dehydration, and reduction typical of fatty 
acid biosynthesis. Four arrows in a row indicate the subsequent steps in the 
bioconversion of pimeloyl-CoA into biotin. 
Both groups examined the 13C incorporation into biotin and 13C-NMR 
spectroscopy of the isolated metabolites revealed labelling patterns 
inconsistent with the synthesis of pimeloyl-CoA from octanoate by a- and 
o-oxidation, nor the formation of pimelate from tryptophan, lysine, 
diaminopimelate or by the a-keto acid elongation of 2-oxoglutarate. 
The independent labelling data found required the two carboxyl groups of 
pimelate to be metabolically distinct and this effectively rules out an 
intermediary role for free pimelic acid. These results reinforce the early 
proposals of Lynen et al. but the authors point out that we are left with 
the evolutionary conundrum that biotin may be directly required for its 
own biosynthesis62. 
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Previous work by Eisenberg and co-workers55 showed the culture filtrate 
of Phycomyces blakesleeanus contained an unknown vitamer incapable of 
binding avidin and unlabelled by [35S]-sulphate indicating the lack of the 
ureido and tetrahydrothiophene bicyclic ring structure. Labelling studies 
implicated an intermediary role in biotin synthesis and early hypotheses 
accounting for the vitamers properties inferred that its biosynthesis 
involved condensation of a three carbon unit, possibly serine or alanine, 
analogous to the formation of 8-amino laevulinic acid from succinyl CoA 
and glycine during porphyrin biosynthesis63. 
The vitamer was subsequently isolated and identified as 7-keto-8-
aminopelargonic acid, 7-KAPA 6. The ability of 7,8-diaminopelargonic 
acid and dethiobiotin to support the growth of yeast and Aspergillus 
nidulans corroborated evidence obtained from genetic experiments. 
Chemical mutagenesis provided biotin auxotrophs of E.coli blocked at 
certain enzymic stages of biotin's biosynthesis and the excretion products 
from the culture filtrates of these mutants were subsequently isolated 
and identified as 7-keto-8-aminopelargonic acid, diaminopelargonic acid 
and dethiobiotin. 
The bioF gene has recently been cloned from Bacillus sphaericus, The 
protein has been overexpressed in E.coli, and the 7-keto-8-
aminopelargonate synthase purified and partially characterised64. The 
enzyme is a monomer of 41kDa with UV absorptions characteristic of 
pyridoxal-5'-phosphate-dependent enzymes. Km values for L-alanine and 
pimeloyl-CoA are 3mM and 1.tM respectively. The protein shares high 
sequence similarity with 5-aminolevulinic acid synthase from 
Bradyrhizobium japonicum which catalyses the condensation of glycine 
with succinyl CoA in the first step of porphyrin biosynthesis. 
The bioconversion of KAPA 6 to DAPA 7 has been demonstrated in 
resting cells of E.coli65,66 and the initial results from both studies have 
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suggested methionine as the most effective amino donor with ATP, Mg2 
and pyridoxal phosphate as cofactors. This combination inferred possible 
in vitro S-adenosylmethionine synthetase (ATP:methionine S-
adenosyltransferase) activity and indeed SAM was ten times more 
effective than ATP and methionine in DAPA formation. The bioA gene 
product has been purified and has been shown to be a dimer of 
approximately 47 kDa per subunit. The source of the amine for the 
transamination is the 2-amino group of S-adenosylmethionine. The 
amino group is transferred by a ping-pong mechanism to the PLP cofactor 
on the enzyme and then onto 7-KAPA65. 
1.9 The Mechanism of Dethiobiotin Synthetase 
Dethiobiotin synthetase (EC 6.3.3.3) is a functionally unique, CO2-
utilising enzyme, which catalyses the formation of the ureido ring of 
dethiobiotin from DAPA. Initial evidence for a precursor-product 
relationship between DAPA and DTB was suggested from genetic and 
biochemical analysis of biotin auxotrophs of E.coli67, and this was 
experimentally confirmed through demonstration of the bioconversion of 
DAPA to DTB, first in resting cells68 and then in cell-free extracts69'70 of 
E.coli. 
Eisenberg and Krell7' purified the E.coli enzyme, established its dimeric 
nature (-50kDa), and found that , in addition to DAPA, the reaction's 
substrate requirements included CO2 , Mg2 ions and ATP. The inability 
of avidin to inhibit the enzyme suggested that this is one of the rare CO2-
utilising reactions that does not involve biotin as a prosthetic group. 
The dethiobiotin synthetase (bioD) gene has recently been cloned from 
both Xbio256 and from E.coli genomic DNA into a modified pBR322 
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homogeneity have allowed a more detailed examination of the mechanism 
of ureido ring closure. 
Baxter et al.73 established the stoichiometry of the overall reaction 
involved formal hydrolysis of one molecule of ATP to ADP and phosphate 
per molecule of dethiobiotin synthesised. To obtain an indication of the 
order in which the three substrates, DAPA, CO2 and ATP are utilised by 
DTBS, they performed a series of competitive experiments where the 
enzyme was preincubated with either [14C]hydrogencarbonate or with 
labelled bicarbonate in combination with either DAPA or ATP. The 
higher incorporation of radiolabel into DTB from enzyme solutions 
preincubated with DAPA and [14C]HCO3- was rationalised by a reaction 
sequence which implicated an intermediate carbamate (9 or 10) derived 





Trapping experiments provided distinction between the two possible 
intermediates (9 and 10) and they proposed the first covalent bond 
forming step of the reaction sequence catalysed by DTBS involved 
formation of carbamate 10 from DAPA. 
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From these results, they inferred the formation of a mixed anhydride of 
the carbamate accompanied the hydrolysis of ATP and they synthesised 7-
[1804]..y,t3..[180]ATP to elucidate the nature of the activated intermediate74. 
Incubation of the labelled substrate with DAPA, HCO3 and Mg2 ions 
and analysis of 180  distribution in the products by 31p  NMR revealed a 
principal ion peak corresponding to [1803, 160]phosphate which implicated 
the transient intermediate formed via pathway A in Scheme 1.6. 
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Scheme 1.6 
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The availability of highly purified dethiobiotin synthetase has allowed its 
crystallisation and subsequent structural refinement to atomic resolution. 
Two groups75'76  have determined the structure of DTBS and their 
respective studies agree on a number of points. The JJ'1'136 monomer 
folds into a compact structure with the parallel p3-sheet forming a core 
surrounded by a-helices as shown in Figure 1.6. 
Fig.1.6 General view of the dimer of DTBS 
The topology of the subunit belongs to the class of a/P domains. The two 
monomers have an extensive contact area and although many of the 
interactions are mediated by water molecules, this may facilitate 
monomer-monomer movement which may occur during enzyme turnover. 
The dimer is saucer-shaped, the concave surface housing the putative 
active site. Alexeev et al.76  found the sulphate ions occupying sites at the 
bottom of the concave surface are consistent with the positions of the 
phosphates in the ATP-binding site. One of the sulphates (Si) is 
postioned exactly in the loop formed by residues 8-16 which is typical of a 
mononucleotide-binding motif known as the P-loop77. They used the 
position of the sulphates and the superposition of the P-loop of the Ha-ras 
oncogene product p21 onto the DTBS structure to model ATP-binding. 
PX 
Corroboration of this model came from X-ray data from a crystal soaked 
in Mg-adenylyl-imidodiphosphate (Mg-AMP-PNP) and dethiobiotin. 
Recent studies78a) have pinpointed the binding site for the DAPA 
substrate on the enzyme (Figures 1.7 and 1.8). It binds at the interface 
between monomers with the carboxyl end in a pocket between Tyr187 
and the main chain N atoms of loop 149-151 at the start of helix a6. The 
hydrophobic region of the substrate makes contacts with the conserved 
1le52. The 7-amino group interacts with Ser4l and Wi while the 8-amino 
group makes contact with Thril. Both groups interact with the sulphate 
ion S2. In solution, the significant absorption change observed at 290nm 
in the absence of ATP corresponds to the rotation of Tyr187 to 
accomodate DAPA in the binding site of DTBS. Refined structural data 
from DTBS crystals under an atmosphere of carbon dioxide has revealed 
that the 7-amino carbamate of DAPA is the true enzyme-bound 
intermediate formed (Fig.1.8) with a concomitant displacement of water 
Wi and sulphate S2. This contradicts the earlier labelling experiments of 
Baxter et al. but this may be due to lyophilisation of the enzyme during 
their work-up protocol which may have initiated carboxyl transfer from 
the 7-amino group to form the more thermodynamically stable 8-amino 
carbamate of DAPA. While there is no significant sequence homology 
between E.coli DTBS and any other protein of known sequence except 
the similar enzymes from B. sphaericus78b), Serratia marcescens78c)  and 
Brevibacterium flavum78d), the 3-D structure reveals similarities with 
three proteins of unrelated sequence, namely nitrogenase iron protein 
from Azotobacter vinelandii (NIP), adenylosuccinate synthetase from 
E.coli and the Ha-ras oncogene product p21. All four enzymes are dimers 
of identical monomers but there is no similarity in the dimer 
organisation. All contain the P-loop structural motif which suggests 
nucleotide binding may be the only common feature between this diverse 
group of enzymes. 
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S2 and water 
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However, the similar folding of the polypeptide chains of the four proteins 
indicates a possible evolutionary relationship and these similarities may 
be features characteristic of a distinct family of ATP-dependent enzymes. 
1.10 The Origin of the Sulphur Donor 
The most unusual step in the biosynthesis of biotin is undoubtedly the 
conversion of dethiobiotin into biotin. The precise nature of the sulphur 
donor and the mechanism of incorporation into dethiobiotin still presents 
two major unsolved problems associated with this transformation. 
Niimura80 utilised sulphur-starved cells of Saccaromyces cerevisiae to 
investigate the effectiveness of various compounds to act as sulphur 
sources in biotin biosynthesis, and found a decreasing order of efficiency: 
methionine sulphoxide, methionine, Na2S, NaHSO4, Na2SO4, 
homocysteine, S-adenosylmethionine and methyl mercaptan. The group 
found that cystine, cysteine, methionine sulphone, S-
methylthioadenosine, choline sulphate and glutathione were inactive as 
sulphur donors. Labelling experiments8' with [35S]-methionine gave 
radioactive biotin. Shimacla82 corroborated this result with tracer studies 
in A.niger. 
Very early tracer studies with Achromobacter had led to the hypothesis79 
of a precursorial role for L-cysteine in biotin biosynthesis according to 
Scheme 1.7. However reinvestigation by Marquet85 refuted the 
hypothesis by incorporation experiments with [3- '4C, 35S] -L-cysteine 
which failed to yield radioactive biotin in the Achromobacter cells. 
Similar experiments on the same organism showed conversion of [2,3-3H,- 
14C]-(±)-dethiobiotin into biotin without change in the tritium to carbon-
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A variety of radiolabelled sulphur compounds have been utilised in 
dethiobiotin incorporation experiments. Although lipoic acid stimulated 
biotin production in A.niger, administration of 35S-lipoic acid gave 
relatively low levels of incorporation in biotin suggesting the stimulating 
effect of lipoate is due to factors other than the donation of sulphur.83 
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The use of thiocystine 13 as a source of sulphur in the biological medium 
offers synchronous availability of both organic reduced sulphur (i.e 
cysteine) and inorganic sulfane sulphur to the cell. Metabolic studies 
using L-[35S-sulfane]-thiocystine demonstrated the compound's ability to 
serve as a sulphur source for E.coli grown in a defined sulphur-free 
medium. The labelled sulphur is rapidly assimilated into cysteine and 
other sulphur-containing metabolites, including biotin. In conclusion, all 
the sulphur atoms of thiocystine were thought to contribute 
approximately equally toward biotin biosynthesis. 
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Alternatively, since Marquet85 was unable to detect significant label 
incorporation from L-35S-cysteine into biotin in Achromobacter, this 
prompted reinvestigation into the contribution of cystine, methionine and 
thiocystine to sulphur metabolism in E.c01i.86 Labelling studies indicated 
that E.coli grown in the presence of L-35S-methionine gave no labelled 
biotin, however the addition of L-35S-cystine led to approximately 80% of 
isolated biotin being labelled. Utilisation of L- [35  S-sulphane]-thiocystine 
by the organism produced biotin possessing approximately 29% of the 
label. 
The equally effective sulphur metabolism of both cystine and thiocystine 
by E.coli prompted DeMoll and Shive86 to explore the ability of these 
sulphur sources to metabolically complement or compete with each other 
as sulphur donors. When E.coli was grown in the presence of 50mM L- 
thiocystine and 75mM L- [35S]  -cystine, approximately 40% of the isolated 
biotin was determined to have incorporated 35S. The theoretically 
possible was 50% if all sulphur was utilised equally. In accordance with 
this observation, addition of L-[35S-sulfane]-thiocystine and unlabelled 
cystine resulted in a significantly lower level of incorporation of 35S. The 
inability of Achromobacter to incorporate 35S from cysteine might be due 
to the inefficiency of the organism to utilise exogeneous cysteine. 
Metabolic studies in E.coli87 have shown that externally supplied cysteine 
must first be oxidised to cystine before transportation and utility by 
E.coli. The close relationship of the precursorial sulphur pool of cysteine 
with that of biotin has been demonstrated by DeMoll and Shive88. 
Feeding experiments with [34S]S042-  and L-[34S-sulfane]-thiocystine in 
E.coli and analysis by GC-MS showed that internal cysteine and excreted 
biotin were labelled to the same extent. 
More recently, investigation into the effect of sulphur compounds on the 
bioconversion of dethiobiotin to biotin by resting cells and protoplasts of a 
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Bacillus sphaericus bioB transformant89 implicated a similar role for L-
cysteine and L-cystine. In marked contrast, results90 obtained from 
sulphur compounds tested in cell free extracts of the same cells found S-
adenosyl-L-methionine was active while both L-cysteine and L-
methionine had no significant effect. Similar results were obtained for 
cell free extracts of E.coli9l. These authors postulated the role of SAM as 
a sulphur donor in biotin biosynthesis but recent labelling studies in cell. 
free extracts of B.sphaericus92 have demonstrated the lack of 
incorporation of 35S from 35S-SAM into biotin. Low incorporation of 35S_ 
label into biotin was observed upon incubation of 35S-L-cysteine in crude 
cell-free extracts of B.sphaericus92 and E.coli.93 Both D- and L-cysteine 
have been found to possess stimulatory effects in a recent study on the 
conversion of dethiobiotin to biotin in cell-free extracts of an E. coli bioB 
transformant94. However, until the experiments can be repeated with an 
active purified system the sulphur donor still remains to be characterised. 
1.11 The Mechanism of Biotin Synthase 
The second major problem associated with the conversion of dethiobiotin 
into biotin concerns the mechanism of sulphur introduction. Early 
investigations by Li et al.96 involved administering a mixture of [1- or 10- 
14C]-dethiobiotin and randomly tritiated dethiobiotin to cultures of 
A.niger and subsequent isolation of radioactive biotin sulfone. From their 
results they postulated that approximately four hydrogens might be lost 
in the conversion of dethiobiotin into biotin, which could be accounted for 
by two unsaturation steps in the overall mechanism. 
The uncertainties resulting from the use of randomly tritiated 
dethiobiotin in these double label experiments prompted a reinvestigation 
into the degree of hydrogen abstraction using specifically tritiated forms 
of dethiobiotin. Parry found that previously published syntheses of 
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dethiobiotin97-100 proved unsatisfactory for specific labelling, due to 
scrambling of the label in later stages and consequently developed a novel 
stereospecific synthesis10' of (±)-dethiobiotin useful for labelling purposes. 
The synthesis was modified to allow the introduction of tritium into the 
possible sites where hydrogen abstraction may occur during sulphur 
insertion, namely C-5 to C-9102,103. 
The samples of tritiated (±)-DTB were each mixed with [10-14C]-(±)-
DTB104 and the doubly labelled precursors were then administered to 
cultures of A.niger (ATCC 1004) using the methods of Li et al.96 The 
precursors were not resolved since only (+)-DTB appears to serve as 
biotin precursor105. The results indicated that sulphur introduction at C-
9 and C-6 took place without loss of hydrogen from C-7, C-8 and C-5. 
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Although unsaturation at any of these sites during the (+)-dethiobiotin to 
(+)-biotin transformation was deemed improbable, the possibility of 
enzymic removal and replacement of hydrogen from these positions 
cannot be ruled out. 
The incorporation of [9-3H]-(±)-DTB 17 into biotin proceeds with about 
30% tritium loss. This is consistent with the removal of one hydrogen 
atom from the methyl group which exhibits little or no isotope effect but 
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the nature of the reaction associated with the oxidation of the methyl 
group of dethiobiotin is still unknown. The incorporation of 6(RS)[6-311]-
(±)-DTB 15 into biotin proceeded with 47% tritium loss. This figure is 
indicative of removal of one hydrogen atom from C-6 of dethiobiotin. 
Thus, Parry concluded that two hydrogens were removed from 
dethiobiotin on its conversion to biotin. 
Parry's work with the eukaryotic organism A.niger was subsequently 
complemented by research from Marquet's group with the prokaryotic 
organism 	E. coli1o6 107• 	[7, 8-3H] - (±)-dethiobiotin 	and 	[5-2H2] -(±)- 
dethiobiotin were prepared using an alternative synthetic approach to 
that of Parry. Each of the labelled dethiobiotins were administered to an 
auxotrophic mutant of E.coli (C124) whose biosynthetic pathway to biotin 
is blocked before dethiobiotin. Administration of [7,8- 3H] -(±)-dethiobiotin 
in conjunction with [1-14C]-(±)-dethiobiotin gave radioactive biotin which 
retained all of the tritium label. The possibility of hydrogen migration 
was dismissed by administration of [7,8-2H2]-(±)-DTB followed by mass 
spectral analysis of the isolated biotin which showed that no loss of 
deuterium had occurred from either position. In a similar experiment [5- 
2H2]-(±)-DTB afforded biotin with retention of both deuterium atoms. 
Finally, administration of [9-2H3]-(±)-DTB to E.coli (C124) gave biotin 
labelled with two deuterium atoms at C-9. This observation agrees with 
Parry's interpretation of the change in tritium to carbon-14 ratio 
accompanying the incorporation of [9-3H, 10-14C]-(±)-DTB in biotin by 
A.niger. 
Parry's investigation into the stereochemical events occurring during 
sulphur insertion was initated by the stereospecific synthesis104  of both 
(6R)[6-3H]-(±)-DTB 18 and (6S)[6-3H]-(±)-DTB 19. 
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The samples of chirally tritiated dethiobiotin were each mixed with [10- 
14C]-(±)-DTB and the doubly labelled precursors administered to A.niger. 
Isolation of (+)-biotin suiphone purified as its methyl ester to constant 
specific activity and constant 14C/3H ratio showed conclusively that 
sulphur is introduced with loss of the 6-pro S hydrogen atom. Since the 
absolute configuration of (+)-biotin at C-B is known to be S108,  it follows 
that sulphur is introduced at C-B with retention of configuration. 
The stereochemistry observed in the nature of the transformation 
suggests that the functionalisation mechanism may be a single step 
process. An alternative possibility such as hydroxylation, activation of 
the hydroxyl group and displacement by a sulphur nucleophile (although 
without precedent) would presumably result in an inversion of 
configuration since biological hydroxylations at saturated C-atoms 
usually proceed with retention of configuration 109. 
Marquet'1° provided evidence against the intermediacy of hydroxylated 
forms of dethiobiotin. 9-Hydroxydethiobiotin 22 and the two epimers of 
6-hydroxydethiobiotin (20 and 21) were synthesised and precursor 
evaluation of the three hydroxydethiobiotin compounds in E.coli C124 

























Transport studies showed that all three compounds can enter the cells so 
the absence of growth could not be attributed to permeability problems. 
Emoto et al.111 also prepared the dihydroxydethiobiotin 23 and obtained 
similar results. On the conversion of dethiobiotin to biotin, it appears 
unlikely that hydroxylation takes place at C-9 or C-fl. However, one 
cannot rule out the involvement of hydroxylated intermediates that are 
tightly bound to the enzyme(s) catalysing the introduction of sulphur. 
In addition to these studies, stereochemical investigation into biotin 
formation by Arigoni"2 demonstrated that chirally labelled [9-3H,2H] 
dethiobiotin was incorporated into biotin with complete loss of chirality at 
C-9. The authors postulate the involvement of a conformationally labile 
methylene radical at C-9. 
Recent investigations have led to the proposition of an intermediary role 
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The intermediacy of the thiol derivatives is attractive on mechanistic 
grounds since insertion of sulphur in a single step would involve 
activation at two separate, saturated sites in a single reaction. Whilst 
the latter reaction has no biosynthetic analogy, closure of a thiol 
intermediate to afford a ring structure is precedented by the ring closure 
of (LLD)-2-aminoadipoylcysteinylvaline to isopenicillin N113. (Scheme 
1.9) 
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Biosynthetic evaluation of the putative precursor 25 began with its 
synthesis by Marquet et al.114. Synthesis of the disulphide dimer of (±)-9-
mercaptodethiobiotin has also been carried out by Baxter et al.115. The 
possible role of (±)-9-mercaptodethiobiotin 25 as an intermediate in biotin 
formation was supported by growth experiments on bio-mutants in E.coli. 
The thiol did not support growth, even at very high concentrations, of 
SA291, a bioABFCD deletion mutant suggesting the compound does not 
substitute for biotin as a coenzyme. However, it was found to support 
normal growth of an E.coli bioA mutant (strain 6435) which requires 7,8-
diaminopelargonate, dethiobiotin or biotin for growth. The evidence 
suggests the primary thiol may act as a biosynthetic intermediate for the 
conversion of dethiobiotin into biotin in E.coli. 
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The synthesis and biological evaluation of the putative intermediate 
thiols in B.sphaericus was recently reported by Marquet et al.116  . Three 
possible thiols (24, 25 and 26) were synthesised and tested for growth 
promoting activity with the biotin requiring strain E.coli C124 ( bioA-). 
One of the secondary thiols 24 was found to be inactive while the other 26 
was almost as efficient as biotin. The primary thiol 25 also promoted 
growth but at significantly higher concentrations. Labelling studies 
using [35S]-26 produced biotin which was devoid of radioactivity. 
Correlation experiments with biotin and epibiotin established that the 
active thiol corresponded to the 6-(R)-isomer 26 with a configuration 
opposite to that of biotin. This result was consistent with [35S] loss and 
they postulated the involvement of an intermediate dithiol 27 which 
allowed the rationalisation of the stereochemistry of sulphur insertion. 
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Introduction of sulphur with inversion at C-6, followed by SN2 type 
substitution would proceed with overall retention of configuration as 
shown by Parry'17 but on synthesis of the postulated disulphides (28 and 
29) , both compounds were found to be inactive in the growth assays of 
E.coli C124. Tracer studies with (+)-[35S]-25 as precursor resulted in only 
1% label retention so the deuterated thiol (+)-9-[2H2]-25 was utilised in 
incorporation experiments. Mass spectrometric analysis revealed a 
complex desulphurisation process. 
Biological evaluation of the three thiols (24, 25 and 26) in the resting 
cells of Bacillus sphaericus revealed that only the primary thiol 25 was 
transformed into biotin with only 10% observed conversion yield 
compared with dethiobiotin. However, incubation of (+)-[35S]-25 with the 
resting cells in the presence of DTT indicated clearly that thiol 25 was 
converted into biotin without degradation. This result was verified by a 
similar study with (+).9- [2H2]- 25 which exhibited no loss of deuterium on 
its bioconversion. 
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The incongruity observed in the growing cells of E.coli and resting cells of 
B.sphaericus necessitated a comparison with the bioconversion by 
growing cells of B.sphaericus since resting cells of E.coli C124 do not 
produce any biotin from dethiobiotin. Experiments with (+)9.[2H2]25 
revealed similar results with those observed with E.coli. Marquet 
concludes that the results are qualitatively identical for growing cells of 
both bacteria and that a complex desuiphurating pathway competes with 
the clean cyclisation observed with resting cells. 
A recent investigation' 8 into biotin biosynthesis in cells of Lavandula 
vera has shown that all bacterial intermediates from pimelic acid could be 
detected in higher plant cells. One of these compounds co-
chromatographed with an authentic sample of 9-mercaptodethiobiotin 
and a labelled sample was incorporated into biotin. The compound was 
also as effective as biotin in supporting the growth of E.coli strain 
bioB105. This evidence strongly suggests the final step of biotin 
biosynthesis in both bacteria and in higher plants proceeds through two 
distinct stages : formation of the primary thiol of dethiobiotin and ring 
closure to give biotin. 
The conversion of dethiobiotin to biotin has recently been demonstrated 
in cell-free extracts of E.coli genetically engineered to overexpress the 
bioB gene product9a).  Among the cofactors tested, ferrous or ferric ions, 
NADPH, SAM and KC1 were found to stimulate the reaction. Similar 
cofactor requirements were found in cell-free extracts of a B.sphaericus 
bioB transformant but in addition to those reported, FAD was also found 
to have a stimulatory effect upon the enzymatic conversjon9lb) Both 
groups agree that an unidentified enzyme(s) beside the bioB gene product 
is required for the bioconversion of DTB to biotin. 
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This development of overexpression systems capable of producing 
relatively large amounts of protein in bioB transformants has led to the 
purification of the protein encoded by the E.coli bioB gene"9. The active 
form of the bioB gene product apppears to be a homodimer (82kDa) which 
contains one [2Fe-2S] cluster per monomer. This protein functions in the 
conversion of dethiobiotin to biotin in crude extracts devoid of the bioB 
gene product. Therefore the 82 kDa protein alone is not sufficient to 
catalyse the biotin synthase reaction since additional unidentified factors 
from the crude extract are required. In addition to these unidentified 
factors, the authors find that both iron and SAM appear to be essential 
for the reaction, and NADPH greatly stimulates it. The required iron is 
in addition to that in the cluster of the bioB gene product. The role of 
additional iron is unknown, although its worth noting the isopenicillin N-
synthase, which catalyses a reaction similar to that catalysed by biotin 
synthase (sulphur added to an unactivated carbon atom), also requires 
loosely bound iron120. However, they found unlike the IPNS reaction 
which requires 02, the biotin synthase reaction proceeds at the same rate 
in both anaerobic and aerobic conditions. The Km for DTB in the biotin 
synthase reaction catalysed by the the mixture of the crude extract of 
KS302bio and the bioB gene product was found to be 2jtM. The turnover 
number based on the amount of bioB gene product was calculated as 1h' 
which is unusually low for an enzyme. This number may increase when 
all proteins neccessary for the reaction are purified and the reaction 
conditions are optimised. 
Analysis of the predicted amino acid sequences of the bioB gene product 
from E.coli, B.sphaericus and S.cerevisiae indicates the conservation of six 
cysteine residues121. Resonance Raman spectroscopy of the E.coli bioB 
gene product affirms the presence of four cysteinyl ligands to the [2Fe-2S] 
cluster of this protein. The presence of an unusual Cys-X-X-X-Cys-X-X-
Cys motif in the three proteins and also in the sequence of E.coli lipoic 
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acid synthase (the lipA gene product) suggests the presence of similar 
iron-sulphur clusters"9 
EPR studies on the E.coli bioB gene product indicate the [2Fe-2S] cluster 
is unstable upon reduction with dithionite and the original spectrum is 
not regenerated when the reduced form is reoxidised. This instability 
may suggest the sulphur added to dethiobiotin possibly originates from 
the Fe-S cluster during catalysis. The function of the unidentified factors 
in the crude extract may involve cluster resynthesis after each turnover. 
Flavodoxin has recently been found to be required for the biotin synthase 
reaction in E.coli.122 The authors suggest that one of the additional 
unidentified protein(s) • still required may therefore be ferredoxin 
(flavodoxin) NADP reductase. In E.coli, flavodoxin is constitutively 
synthesised and provides electrons for the reductive activation of 
pyruvate formate-lyase'23 and cobalamin-dependent methionine 
synthase124, both of which require SAM as a cofactor. Recent studies on 
lysine 2,3-aminomutase'25 and anaerobic ribonucleotide reductase126 
show reaction similarities between the two enzymes and the reaction 
catalysed by biotin synthase. The presence of an Fe-S cluster, the 
requirement of SAM and the removal of hydrogen from an unactivated 
carbon atom all suggest formation of a radical in the biotin synthase 
reaction. 
The fact that (9R)[9-1H,2H,3H]-dethiobiotin administered to resting cells 
of A.niger results in scrambling of the isotopes in the isolated biotin with 
its implication that a conformationally labile methylene radical may be 
formed at C-9 of dethiobiotin supports this observation. 
The scope of this research was to investigate the mechanistic aspects of 
biotin biosynthesis in E.coli , in particular the reactions catalysed by 
dethiobiotin synthetase and biotin synthase. 
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Chapter 2 
The Mechanism of Dethiobiotin Synthetase 




Dethiobiotin synthetase (EC 6.3.3.3) catalyses the first ring closure in the 
biosynthesis of biotin, resulting in the formation of the ureido ring of 
dethiobiotin (DTB) 8 from (7R,8S)-7,8-diaminononanoate (DAPA) 7 
(Fig.2. 1) 
+ + 	 Co2 	 0 
H3N NH3  
H 8 7H 	 1 	
Mg2 	HN'NH 
2 	0  2 H 	H - 
9 	6 	4 	2 
ATP ADP 
8 
Fig.2.1. The reaction catalysed by dethiobiotin synthetase (DTBS) 
This process is of particular interest in that it is one of the few "carbon 
dioxide" trapping reactions known to date which does not involve biotin 
as a prosthetic group. It shares distinction with the C-carboxylating 
enzymes phosphoenolpyruvate carboxykinase 127,  ribulose- 1, 5-diphosphate 
carboxylase/oxidase'28 and the vitamin K dependent protein glutamyl 
carboxylase129 as one of the few biocatalysts which utilise CO2 in 
preference to hydrogen carbonate as a substrate. However DTBS 
remains unique since it is the only one to involve N-substrate 
carboxylation in its mechanism. These aspects have received great 
attention from researchers resulting in the enzyme's purification72, 
characterisation of the intermediary events involved in the ureido ring 
formation73'74 and ultimately its crystaffisation72 and structural 
characterisation to atomic resolution75'76. 
The kinetic aspects of this unique transformation have been 
investigated130 employing both stopped-flow and steady-state kinetic 
techniques to characterise the nature and the sequence of the individual 
steps involved in the mechanism of DTBS. 
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2.2 Synthesis of aberrant DAPA analogues 
The information obtained from both crystallographic and kinetic 
characterisation of this enzyme has prompted the synthesis of modified 
substrates as probes to explore the limitations of the DAPA binding site 
and examine the synthetic versatility of the reaction catalysed by DTBS. 
The 9-methyl group and 7-hexanoate side chain were identified as sites 


























Fig.2.2 Aberrant DAPA analogues targetted for synthesis 
A large number of potential synthetic routes could be employed for 
analogue synthesis and there are a plethora" of biotin syntheses reported 
in the chemical and patent literature. However, the synthetic approach 
to these analogues was limited to proven methodology successfully 
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Fig2.3 Retrosynthetic analysis of DAPA 
Retrosynthetic analysis of DAPA indicated that the Friedel-Crafts 
acylation of imidazolin-2-one could provide a convenient route to the 
target compounds (see Fig.2.3). This route can accomodate the proposed 
modifications of the native substrate skeleton, and the modifed 
tetrahydroimidazolin-2-ones are immediate precursors to both 
dethiobiotin and DAPA analogues so potential inhibitors for DTBS and 
biotin synthase could be obtained from the same synthesis. 
0 
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4-Methyl-4-irnidazolin-2-one 39 was prepared by condensation of acetol 
37 and urea 36 in 25% yield. This one-pot synthesis'3' allowed 
modification of the alkyl moeity and the corresponding 4-ethyl-4-
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Imidazolin-2-one 42 was prepared by the method of Hilbert132 which 
involved the condensation of urea 36 and (+-)-tartaric acid 41 in fuming 
sulphuric acid to give the imidazolinone-4-carboxylic acid upon which 
subsequent decarboxylation with potassium carbonate gave the 
corresponding irnidazolin-2-one 42 in 75 % yield. 
Friedel-Crafts acylation was performed on the substituted imidazolinones 
with acid chlorides of varying chain length (see Scheme 2.1) and the 
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30R=H, n=4 33 R=Me, =3 	 49 R=H, n=4 52 R=Me, n=3 
31 R=Et, n=4 34 R=Me, n=5 50 REt, n=4 53 R=Me, n=5 
32R=Me, n=2 35 R=Me, n=6 	 51 R=Me, n=2 
54 R=Me, n=6 
Scheme 2.1 Synthetic route to racemic DAPA analogues 
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R n Product Yield 
(%) 
CHN calcd. (%) CHN found (%) 
H 4 43 35 C 55.0,H,6.7,N,11.65 C,55.2,H,6.65,N,11.4 
Et 4 44 30 C,58.2,H,7.5,N,10.45 C,58.45,H,7.45,N,10.3 
Me 2 45 39 C,53.1,H,6.25,N,12.4 C,53.1,H,6.3,N,12.3 
Me 3 46 42 C,55.0,H,6.7,N,11.65 C,54.65,H,6.5,N,11.65 
Me 5 47 40 C,58.2,H,7.5,N,10.45 C,58.0,H,7.8,N,10.15 
Me 6 48 33 C,59.55,H,7.85,N,9.9 C,59.4,H,7.55,N, 10.0 
Table 4.1. Products obtained from the Friedel-Crafts acylation of substituted 
irnidazolin-2-ones. Yields were calculated from the starting imidazolin-2-one 
39, 40 or 42. 
Compounds 43-48 were hydrogenated over Adam's catalyst (Pt02) at 
room temperature and atmospheric pressure to give the corresponding 
racemic dethiobiotin ethyl ester analogues 49-54 (see Table 4.2) 
R i,. Product Yield 
(%) 
FAB MS required FAB MS found 
H 4 49 85 229.1552 229.1551 
Et 4 50 65 257.1865 257.1865 
Me 2 51 90 215.1395 215.1403 
Me 3 52 77 229.1552 229.1549 
Me 5 53 88 257.1865 257.1865 
Me 6 54 78 271.2022 271.2021 
Table 4.2 Products from the catalytic hydrogenation of the substituted 
imidazolinones 
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The racemic DAPA analogues 30-35 were obtained from the 
corresponding aberrant (±)-dethiobiotin ethyl esters by hydrolysis with 
barium hydroxide in a sealed vial for three days (see Table 4.3). The 
success of the reaction was identified by the disappearance of the 
characteristic ureido carbonyl group at 164ppm in the 'C nmr spectra of 
these DAPA analogues. 
R n Product Yield 
(%) 
CHN calcd. (%) CHN found (%) 
H 4 30 55 C,35.3,H,7.35,N,10.0 C,35.25,H,7.1,N,10.0 
Et 4 31 35 C,40.0,H,8.05,N,9.3 C,39.7,H,8.35,N,9.1 
Me 2 32 45 C,32.5,H,7.0,N,10.85 C,32.2,H,6.9,N,10.9 
Me 3 33 57 C,35.3,H,7.4,N, 10.3 C,35. 1,H,7.5,N, 10.25 
Me 5 34 48 C.40.0,H,8.05,N,9.3 C,40.0,H,8.35,N,9.1 
Me 6 35 52 C,42.0,H,8.35,N,8.9 C,42.3,H,8.7,N,8.9 
Table 4.3 Racemic DAPA analogues obtained from the hydrolysis of the 
corresponding (±)-dethiobiotin ethyl ester analogues 
The isolated compounds were used in subsequent biological experiments 
as their racemates as it appears the enzyme is specific for the (R,S)-
isomer of the substrate and the (S,R)-isomer exhibits little or no 
inhibitory effects. 
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2.3 Kinetic Studies 
2.3.1 Catalytic activity of the aberrant analogues 
The efficiency of the analogues to act as enzymic substrates was 
determined spectrophotometrically using a linked assay by which the 
ATP to ADP conversion was monitored by assay of ADP produced. The 
oxidation of NADH was coupled to the production of ADP by the addition 
of phosphoenolpyruvate, pyruvate kinase and lactate dehydrogenase in 
excess. Enzyme kinetic experiments were performed by Dr. Otto Smekal 
and the steady-state kinetic parameters obtained for these analogues are 
shown in Table 4.4 
DAPA analogue R n Km(app) (M) kcat(app) 	(s kcatlKm(app) 
(±)-DAPA 55 Me 4 4.1 x 10-6 8.3 2.0 x 106 
(R-1)-(±)-DAPA 30 H 4 1.2 x 10-2 0.5 4.5 x 101 
(R+1)-(:L)-PAPA 31 Et 4 9.0 x 10-3  2.0 2.2 x 102 
(n-2)-(±)-DAPA 32 Me 2 4.5 x 10 1.7 3.8 x 102 
(n-1)-(:h)-DAPA 33 Me 3 2.1 x 10 2.7 1.3 x 10 
(n+1)-(±)-DAPA 34 Me 5 3.5 x 10 4.0 1.1 X 10 
(n+2)-(±)-DAPA 35 1 	Me 1 	6 5.3 x 10 0.5 9.4 X 10' 
Table 4.4. Steady-state kinetic parameters obtained for aberrant DA-PA 
analogues. Initial rate coefficients for each analogue were determined at a fixed 
concentration of enzyme and under conditions where all other native co-
substrates (CO2, ATP and Mg2 ) were held at concentrations of Ca. 5Km. 
(appapparent) 
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The above results reflect that all the analogues are substrates of DTBS 
but all are poorer than the racemic parent substrate. Comparison 
between analogues (n-i) and (n+1) indicates that increasing or decreasing 
the aliphatic backbone by one CH2 group results in a similar fall in 
catalytic efficiency. Lengthening the native chain by two methylene 
groups results in a further decrease in the kcat/Km ratio but by one order 
of magnitude less than shortening the side chain by two carbons. It is 
apparent that DTBS is extremely versatile in its ability to utilise 
aberrant substrates of varying chain length but the enzyme functions at 
the optimum rate only with the native hexanoate side chain present in 
DAPA. 
Replacing the methyl group of DAPA with H results in a dramatic fall in 
catalytic efficiency by five orders of magnitude. Kinetic studies on the 
ethyl analogue, (R+1)-(±)-DAPA, 31, gave a similar drop in kcatlKm(app) 
ratio but only by four orders of magnitude. Removing the methyl group 
from the native substrate appears to have the most drastic effect. The 
conformational freedom induced by this subtle change in substrate 
structure may suggest the aberrant DAPA analogue cannot adopt the 
correct conformation for DTBS-substrate complex formation. The 
presence of the methyl group of DAPA may help to stabilise the enzyme-
substrate complex through putative interaction with hydrophobic 
residues on the enzyme. If so then the large drop in catalytic efficiency 
observed with the ethyl DAPA analogue might be attributed to steric 
interactions associated with the conservative replacement of a methyl 
group to an ethyl group (see Section 2.4) 
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2.4 Binding studies 
The range of kcat/Km ratios observed for these pseudo-subtrates 
necessitated a study of their interaction with DTBS to determine how 
alteration of the native structure affects the initial substrate binding to 
the enzyme. 
The first reaction catalysed by DTBS proceeds in two distinct stages. The 
first step involves the binding of DAPA to DTBS to form a subtrate-
enzyme complex. Secondly, this complex reacts with CO2 to afford a 
DTBS-DAPA carbamate complex. This is shown in Fig.2.4 
kj 	 k2 
DAPA + DTBS ____ DAPA-DTBS + CO2 	DAPA-DTBS.0O2  
k1 	 k2 
Fig.2.4 Kinetic model for the first two steps of the DTBS reaction in the 
absence of ATP. 
The results of trapping experiments130, UV absorption changes upon 
substrate binding and on subsequent reaction with CO2 lend support to 
this model. Absorption maxima at 290(±4) and 301(±3) nm correspond to 
the DTBS-DAPA complex and the DTBS-DAPA.0O2 state respectively. 
Thus, stopped-flow experiments have allowed the first two steps in the 
reaction to be quantified spectrophotometrically. 
In the absence of cooperative interactions between substrate binding sites 
each of the above steps can be treated as pseudo-first-order processes 
with the rate coefficients kobsi and kobs2. Measurements of the specific 
rates of binding of DAPA and its analogues to DTBS were determined 
over a DAPA (analogue) concentration range of 10-500jiM in the presence 
of Mg2 (2mM). Analysis of the spectrophotometric data using a non-
linear regression approach allowed calculation of the DTBS-DAPA 
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(analogue) equilibrium dissociation constant. The results of these 
binding studies are shown in Table 2.5 
From the results, it is apparent that the modifications in the parent 
substrate significantly alter the rates of DTBS-DAPA analogue complex 
formation. The modified DAPA analogues 33-35 which differ only in 
chain length exhibit slow interactions with ki's for association one order 
of magnitude lower than racemic DAPA. However, the variation in R 
group resulted in a reduction in the rate of association by two orders of 
magnitude for (R-1)-(±)-DAPA 30 and (R+1)-(±)-DAPA 31 with ki values 
of 0.35 and 0.5 s-1 respectively. These results suggest that the 
stereochemical binding constraints imposed by DTBS lowers the rate of 
binding, of these compounds to the enzyme (in the absence of ATP). 
SUBSTRATE R n Kdi (M) ki (M-'s-') k-i (s-i) 
(±)-DAPA 55 Me 4 3.7 x 10-3  12.0 4.4 x 10-2 
(R-1)-(±)-DAPA 30 Me 4 3.0 x 10-5 0.5 1.5 x 10-5  
(R+1)-(±)-DAPA 31 Me 4 5.0 x 10 0.35 1.75 x 10 
(n-2)-(±)-DAPA 32 Me 2 1.05 x 10 1.7 1.8 x 10 
(n-1)-(±)-DAPA 33 Me 3 2.2 x 10-4  2.3 5.1 x 10- 
(n+1)-(±)-DAPA 34 Me 5 1.8 x 10- 4.7 8.5 x 10 
(n+2)-(±)-DAPA 35 1 Me 6 	1 4.3 x 10 0.8 3.4 x 10 
Table 2.5 Binding constants for the interaction of DTBS with DAPA analogues 
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The association rate constants for 30 and 31 indicate that the removal or 
extension of the 9-methyl of DAPA significantly alters the binding of the 
analogue to the enzyme. Indeed, crystallographic analysis78 of the native 
substrate in the active site of DTBS suggests that the 9-methyl group of 
DAPA may form a hydrophobic contact with the ring methylenes of 
Pro79. Here it should be noted that proline is one of the more 
hydrophobic amino acid residues with a hydrophobicity index of 10.91 . 
Upon binding, the pseudosubstrates exhibit rates of dissociation between 
two and three orders of magnitude less than the racemic parent 
substrate. These results seemed rather surprising since, on DTBS-DAPA 
analogue complex formation, it was thought that the modified substrates 
would bind less well which would lead to an increase in the rate of 
dissociation. It appears however that shortening or lengthening the 
native chain may reduce steric interactions or increase hydrophobic 
contact with the enzyme. This rationale may also apply to the interaction 
of (R-1)-(=L)-DAPA 30 and (R+1)-(±)-DAPA 31 with DTBS where replacing 
the methyl group of DAPA with H or Et contributes to the significant fall 
in dissociation rate constant, k1, observed for these two analogues. 
These initial observations suggest that it is binding of these analogues to 
the enzyme which is rate-limiting in the DTBS catalysis of ureido ring 
formation. However, since these experiments were performed in the 
absence of ATP it must be noted that the possible conformational changes 
induced by bound ATP could affect the binding of DAPA and its 
analogues. 
We also examined the kinetics of the second step of the DTBS 
transformation, namely the reaction of CO2 with the DTBS-DAPA 
analogue complexes to form the enzyme-bound carbamate. These results 
are summarised in Table 2.6 
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SUBSTRATE R n Kd2 (M) k2 (M's-1) k.2 (s-') 
(±)-DAPA 55 Me 4 4.7 x 10-2 3.8 0.18 
(R-1)-(±)-DAPA 30 Me 4 1.2 x 10.2 1.8 0.002 
(R+1)-(±)-DAPA 31 Me 4 6.3 x 10-3 0.7 0.004 
(n-2)-(±)-DAPA 32 Me 2 2.0 x 10-2 2.7 0.054 
(n-1)-(±)-DAPA 33 Me 3 2.7 x 10-2 3.2 0.090 
(n+1)-(±)-DAPA 34 Me 5 1.1 x 10.2 1.5 0.017 
(n+2)-(+)-DAPA 35 1 Me 1 	6 4.5 x 10-2 2.6 0.120 
Table 2.6 Kinetic data obtained for the reaction of CO2 with the DTBS-DAPA 
analogue complex 
The data obtained suggests that in all cases the rate of DTBS-DAPA 
analogue carbamate formation is similar to that of the native substrate. 
All the pseudosubstrates, with the exception of 31 (k2 0.70 M's'), have 
k2 values within the same order of magnitude as (±)-DAPA 55. The 
increase in size of the alkyl moeity in 31 may introduce a steric constraint 
which forces the 7-amino group out of the optimal binding site and thus 
slows carbamate formation. It is noteworthy that, once formed, the 
aberrant carbamates do not readily dissociate from the enzyme on 
comparison with DAPA-0O2. The synthetic modifications may act to 
stabilise the carbamate intermediate, a feature already observed in the 
binding of the substrate analogues to DTBS. 
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2.5 Modelling studies of the active site of DTBS 
The results obtained from the kinetic studies clearly show that all the 
DAPA analogues synthesised act as slow substrates of DTBS. Although 
comparison of the kinetic parameters suggests differences in binding, it is 
difficult to recognise a clear pattern at this stage without the aid of X-ray 
studies. Recent crystallographic characterisation134 of the enzyme-DAPA 
and enzyme-DAPA carbamate complexes in the presence and absence of 
Mg2 ions carried out in this laboratory have revealed details of protein-
substrate and protein-intermediate interactions which stabilise the 
binding of DAPA and the DAPA N-7 carbamate intermediate to the active 
site of the enzyme. (see Figs. 1.7 and 1.8) 
The role of Mg2 ion in the DTBS reaction has also been determined 
crystallographically and the conformational changes between the Mg2 
substrate-enzyme complex (coloured atoms) and the Mg2 free complex 
(white atoms) are shown in Fig.2.5 
In the absence of Mg2 , the Thril and Ser4l hydroxyls are directed away 
from the substrate binding site. However, in the Mg2-comp1exed form, 
the Thrii-Ser4l Ca-Ca distance is shortened by 1.3 A and both side 
chain hydroxyls are rotated towards the diamino group binding site. The 
substrate is bound between the two crystallo graphically identical 
monomers of the dimeric DTBS. 
Earlier work76 has suggested that the positions of the two bound 
sulphates, Si and S2, could be considered to mimic the positions of the a-
and y-phosphates of the ATP molecule. Thus, binding of Mg2 to the 
enzyme leads to a movement of the P loop which has two consequences: 
the phosphate binding site alters to permit better binding of the a- and y-
phosphates of ATP and the hydroxyl groups of Thril and Ser4l rotate 
towards the bound Mg2 , and each other, allowing formation of H-bonds 
between these residues and the amine groups of the substrate. 
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Fig.2.5 The conformational changes induced by Mg2 ions. The coloured 
molecule represents the Mg2 complex and the open molecule corresponds to the 
Mg-free enzyme.(Figure drawn with MOLSCRIPT135) 
X-ray structures of the DTBS-DAPA-Mg2 complex in the absence 
(Fig.1.7) and presence of CO2 (Fig.1.8) were determined on a single 
crystal and these show in detail that carboxylation occurs at the N-7 
amino group of DAPA. The sulphate S2, which is present before DAPA 
carboxylation and which is coordinated to the Mg2 ion, the -amino 
groups of Lys37 and Lys15, and water molecule W2, is replaced by the 
carboxylate group of DAPA carbamate and by a water molecule Wi. 
Small movements (up to 0.3A) of the Mg2 ion, the sulphate anion Si and 
the P-loop close the gap left by the displacement of the S2 sulphate. 
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In all the complexes studied, the difference electron density maps have 
shown unambiguously that the substrate and the intermediate bind to 
the same site in the enzyme. While the interactions at the diammo end of 
the substrate differ significantly in the two enzyme-substrate complexes 
(i.e in the presence and absence of CO2), the binding of the carboxyl group 
of the ligand is always the same. The carboxylate of DAPA (piCa 4.48) 
interacts with the positive (N-terminal) pole of the helix a6 (see Fig.2.5). 
One carboxylate oxygen binds to the main chain nitrogen of Asn 153 and 
the other is held between the positively polarised main chain nitrogens of 
G1y150-Cys151-11e152 and the hydroxyl of Tyr187, which moves to 
optimise substrate binding. A similar carboxylate helix dipole interaction 
has been observed in D-ala-D-ala ligase137. 
The hydrophobic side chain of the bound DAPA lies in a groove defined by 
Ca of Gly118, C72 of Thr122, Ca of Ser8l and C8 of Pro82 on the other 
subunit of the native structure. The side chain of Leu149 moves some 
2.5A towards the substrate providing an additional hydrophobic 
interaction with the polymethylene chain which helps to lock the 
substrate in the groove of the opposite subunit. 
In contrast, the binding pattern at the amino end of the substrate is 
variable and subject to conformational changes of the enzyme depending 
on the nature of the ligand and the presence of Mg2 . These changes 
suggest that the carboxylate end serves to anchor the substrate to the 
enzyme presenting the diamino functionality to the catalytic site on the 
other subunit. 
We used this common interaction as a basis for modelling two of the 
aberrant analogues in the active site of DTBS. Models for (n-1)-DAPA 
and (n-2)-DAPA were constructed on the assumption that the 
carboxylate-helix dipole interaction remained the same upon binding and 
that H-bonding interactions between the enzyme and the amino function 
of the substrates would be maximised. 
54 
Figures 2.6 and 2.7 represent models for the interaction of DTBS with 
(n- 1)-DAPA and (n-2)-DAPA respectively. 
It is apparent that the constraints imposed by the carboxylate binding 
site in both models direct a conformational change in amino group 
binding such that the terminal amino group is presented for 
carboxylation. This is opposite to that found in DAPA where the N-7 
amino group is the site of carbamate formation. 
The information derived from these models suggests that DTBS may 
catalyse an alternative mechanism of ureido ring closure when utilising 
32 and 33 as substrates. However, the active site models only provide a 
hypothetical view of analogue binding and more detailed structural 
analysis of the aberrant analogues in the active site was required to 





DAPA in the 









Asp54 	 S2 
Tyris 
Fig.2.7 Active 








2.6 Crystallographic studies on the binding of (n-1)-DAPA to 
DTBS 
Crystallographic studies on DTBS performed in our laboratory76"34 have 
allowed the interaction between the enzyme and aberrant DAPA 
analogue 33 to be examined at atomic resolution. Structural analysis of 
the protein-analogue interaction was performed in collaboration with Dr. 
Dimitriy Alexeev and the results of this study are described below. 
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Fig.2.8 Stereoview of (n-1)-DAPA bound in the active site of DTBS. The 
pseudosubstrate lies between the two monomers of the enzymic homodimer. 
(Figure was drawn with MOLSCRIPT135) 
The (n-1)-DAPA compound binds to DTBS in a similar manner to the 
native substrate where analogue is straddled between the monomers of 
the enzyme homodimer (see Fig.2.8). Carboxylate binding is identical to 
the parent DAPA substrate and the rotation of Tyr187 on helix a7 
towards the positive pole of helix a6 is clearly visible. 
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However, the shortened side chain directs a conformational change at the 
amino terminus and the site occupied by the N-7 amino group in DA-PA is 
now replaced by the terminal amine in (n-1)-DAPA as suggested by our 
modelling studies. Both amines of the aberrant analogue are coordinated 
to Ser4l while the N-7 amino group of (n-l)-DA-PA is H-bonded to the 
sulphate anion S2 and the water molecule W2. In addition, the 
monomers of the enzyme move approximately 0.4 A closer together to 
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Fig.2.9 Site of DAPA carboxylation and putative site of (n-1)-DA-PA carbamate 
formation 
We were not able to detect the carboxylation of (n-l)-DA-PA 
crystallographically which would have identified the site of carbamate 
formation unambiguously. However, the fact that the carboxylation 
active site of the enzyme is now occupied by the 7-amino group of (n-i)-
DAPA suggests that this amine is carboxylated (Fig.2.9). If so, then it 
appears that DTBS exhibits remarkable versatility in dealing with small 
changes in substrate structure by catalysing the ureido ring closure of (n-
1)-DAPA through an alternative mechanism. 
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2.7 Conclusions 
The combination of kinetic, modelling and crystallographic studies have 
demonstrated that DTBS exhibits promiscuity in utilising aberrant 
DAPA analogues as substrates. Further experiments are required to 
determine if the enzyme employs a variable mechanism of ureido ring 
closure to achieve its catalytic goal. Fortunately, the scope of these 
analogues is not limited to studies on DTBS. Since the catalytic products 
of the DTBS reaction are modified dethiobiotin analogues, these 
compounds could be used as probes to study the limitations of sulphur 
introduction in the biotin synthase reaction. Enzymatic radiolabeffing of 
these analogues with H14CO3 would provide a clean and efficient 
alternative to labelling with 14C-phosgene. The information obtained 
from this study may prove useful in the targetted design of inhibitors of 




The Mechanism of Biotin Synthase- 
Enzymatic Studies on the Nature 
of Sulphur Donation 
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3.1 Establishing an in vitro system 
Since Dittmer et al.53 first demonstrated that dethiobiotin was as effective 
as biotin in supporting the growth of Saccharomyces cerevisiae, a large 
number of studies have appeared in the literature confirming that 
dethiobiotin is converted to biotin by resting and growing cells of a 
variety of organisms137. However, work on the identification of the 
sulphur donor and the mechanism of this unique reaction has awaited the 
development of overexpression systems capable of producing sufficient 
amounts of the enzyme involved for mechanistic investigation. 
Previous studies93 in this laboratory have involved the cloning of the 
E.coli bioB gene into a high level expression vector (pKK233-3), a plasmid 
with a relatively high copy number containing the tac promoter, to 
produce the recombinant plasmid pIMSB. This plasmid was used to 
transform E.coli strain DH1i (bio+) to give the bioB transformant 
DH1iJpIMSB. Production of biotin by induced DH1iJpIMSB cells (when 
excess DTB was present) was approximately 100 times that of wild type 
E.coli K-12. 
During our initial investigations into establishing a functional in vitro 
system using cell-free extracts of DH1iIpIMSB, Ifuku et al.9t) 
demonstrated the enzymatic conversion of dethiobiotin to biotin in cell-
free extracts of a bioB transformant of E.coli. Their investigation into the 
cofactor requirements of this reaction indicated that ferrous or ferric ions, 
S-adenosyl methionine (AdoMet). NADPH, KC1 and fructose-1,6-
bisphosphate all stimulated the production of biotin from dethiobiotin. 
Following this work, we also found similar cofactor requirements 
although in our hands fructose-1,6-bisphosphate does not significantly 
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Fig 3.1. Plot of amount of biotin made with time. Biotin-forming activity was 
assayed under standard assay conditions using DH1iIpIMSB cell-free extract in 
the presence of 5mM Fe2 , 0. 1mM AdoMet, 1mM NADPH, 10mM KC1, 5mM L-
cys and GOp.M D-DTB. 
In our preliminary studies on the purification of biotin synthase we also 
found, in agreement with Ifuku et al., that an additional protein(s) was 
required for the enzymatic conversion of dethiobiotin to biotin. 
Ammonium sulphate fractionation of DH1iJpIMSB cell-free extracts 
showed that proteins precipitating between 20 and 50% saturation, in 
which the bioB gene product was thought to be included on the strength 
of SDS-PAGE, did not show any biotin-forming activity by itself. 
However, biotin production was detected using the Lactobacillus 
plantarum microbiological assay138 when the reaction mixture was 
supplemented with cell-free extracts of PCOi (bio-), an E.coli mutant 
which the lacks the biotin operon. 
Anion exchange chromatography of the 20-50% ammonium sulphate 
fraction of DH1iIpIMSB gave the elution profile shown in Fig.3.2 
Fractions were analysed by SDS-PAGE and assayed for biotin synthase 
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Fig-3.2 Q-sepharose anion exchange chromatography of 20-50% (NH4)2SO4 
fraction of DH11IpIMSB. 
The bioB gene product eluted at a salt concentration of approximately 
300mM. 
During the course of this work, Flint and coworkers at Du Pont reported 
the first purification of the E.coli bioB gene product"9. The protein is a 
homodimer (82kDa) and contains one [2Fe-2S] cluster per monomer. In 
common with Ifuku's group and ourselves, they observed that the bioB 
gene product alone was insufficient in catalysing the formation of biotin 
from dethiobiotin and required unknown cofactors from crude extracts 
devoid of the bioB gene product. One of these unknown cofactors has 
been identified as flavodoxin122. However addition of flavodoxin alone to 
partially purified extracts of bioB gene product and other cofactors did 
not result in formation of biotin. The results of this study suggest that 
another unidentified protein(s) in addition to the bioB gene product and 
flavodoxin may be involved in the biotin-forming reaction. The authors 
postulate the possible involvement of ferredoxin (flavodoxin) NADP 
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reductase in this system but attempts at isolation have proved 
unsuccessful. 
Although a purified system for in vitro biotin formation remains to be 
found, the information obtained from these recent investigations has been 
used to draw similarities between the reaction catalysed by biotin 
synthase and those of other enzymes. Of particular note is the 
requirement for Adomet in the reaction. Adomet is normally regarded as 
the source of methyl in methylating enzymes139 although it has been 
implicated as an amino donor in DAPA synthase65'66. More relevant to 
this work is its role as a free radical initiator in the action of pyruvate 
formate lyase (PFL), anaerobic ribonucleotide reductase (anaRNR) and 
lysine 2,3-aminomutase. Since it is this action which is relevant to the 
biotin-forming activity of biotin synthase, some discussion of the 
mechanisms of these enzymes is relevant here.Their catalytic actions are 
shown in Fig. 3.3 
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Fig.3.3 The reactions catalysed by pyruvate formate lyase (PFL), anaerobic 
ribonucleotide reductase (anaRNR) and lysine 2,3-aminomutase 
A common dependence amongst these enzymes is the requirement of S-
adenosylmethionine (AdoMet) in the reaction. The 5'-deoxyadenosyl 
radical produced by the one electron reduction of AdoMet is used to 
activate the enzyme by initiating a protein-based radical, as occurs with 
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PFL and anaRNR, or it may participate directly in catalysis as in the 
reaction catalysed by lysine 2,3-aminomutase. 
Under anaerobic conditions, the activation of PFL is achieved by 
generating a radical at a specific glycine residue (g1y734), which is 
predicted to he in a a-turn of the protein140. The specific activating 
enzyme responsible for generating the glycyl radical'41, PFL activase, 
requires Fe(II) for activity, AdoMet and inactive PFL as substrates, with 
reducing power supplied by reduced flavodoxin. In addition, pyruvate is 
required as an allosteric activator. AdoMet is first reduced to the 5'-
deoxyadenosyl radical and methionine by a single electron from 
flavodoxin, presumably mediated by Fe(II). The radical removes 
hydrogen from the C-a of PFL-g1y734. This step has been demonstrated 
by stoichiometric incorporation of deuterium into 5'-deoxyadenosine from 
2-D-glycine labelled PFL142. The peptide in which g1y734 is replaced by 
L-alanine is inactive; however, the D-alanine-substituted peptide is a 
good substrate, which implies that the activase is stereospecific for the 
pro S hydrogen of PFL-gly734. 
The AdoMet-dependent activation of the anaerobic ribonucleotide 
triphosphate reductase (anaRNR), which also requires reduced 
flavodoxin, most probably occurs in a manner similar to that described for 
PFL143 but differs in its apparent "self-activation" i.e no auxiliary 
activase is required. The enzyme contains a [4Fe-4S] cluster which is 
presumably involved in the reduction of AdoMet to 5'-deoxyadenosyl 
radical and methionine. In common with PFL, this radical is used to 
generate a protein radical by removing hydrogen froma glycine residue 
which, upon sequence comparison with PFL, appears to be gly681144.  
The third AdoMet-utilising enzyme, lysine 2,3-aminomutase, contains a 
[4Fe-4S] cluster and Co(II), which are essential for activity145. However 
the chemistry associated with forming the 5'-deoxyadenosyl radical from 
AdoMet remains obscure since no external reductant is apparently 
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required by the enzyme. Various mechanistic hypotheses have been 
discussed and suggest that the iron-sulphur centre supplies an electron to 
reduce AdoMet146. Experiments have demonstrated that tritium from 
AdoMet labelled in the 5' position is transferred to both the substrate, 
lysine, and the product, -lysine, thus implicating a direct role for the 5'-
deoxyadenosyl radical in catalysis147. In agreement with this role, the 5'-
deoxyadenosyl radical and methionine remain tighly bound to the enzyme 
during catalysis, although some slow release of 5'-deoxyadenosine and 
methionine occurs. The presence of Co(II) has led to the suggestion that 
(by analogy with adenosylcobalamin), the 5'-deoxyadenosyl radical could 
be stabilised between turnovers by coordination to the cobalt. 
Radical chemistry has already been postulated in the bioconversion of 
dethiobiotin to biotin. Arigoni et al. synthesised dethiobiotin chirally 
labelled at the 9-position with hydrogen, deuterium and tritium to probe 
the mechanism of proton abstraction on its conversion to biotin in 
A.niger"2. 
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Fig.3.4 The proposed radical chemistry involved in the conversion of [9-2H, H]-





The stereodistribution of the isotopes at C-i of the isolated biotin 
indicated that scrambling of the isotopes had occurred. From this, the 
authors suggested the formation of a conformationally labile methylene 
at C-9 as an intermediate in the biosynthesis of biotin. (Fig. 3.4). The 
results from this experiment and analogy with other enzymes suggests a 
role for AdoMet in producing a radical species involved in the biotin 
synthase reaction. 
3.2 Identification of the sulphur donor 
After establishing an active in vitro system, we focussed our attention 
upon the identity of the sulphur donor in the enzymatic formation of 
biotin. 
There is growing evidence in the literature that cysteine, if not the actual 
sulphur donor, is very close to the metabolic pathway whereupon sulphur 
is introduced into biotin86'88. However, incorporation experiments with 
intact organisms have been hampered by poor uptake of exogeneously 
supplied precursors and this has compelled studies at the cell-free level. 
Studies in cell-free extracts of B.sphaericus have shown that the 
radiolabel from 35S-AdoMet is not incorporated into biotin thus 
supporting the view that AdoMet acts as a cofactor and not as a sulphur 
source92. 
However, we observed no significant increase in biotin production on 
administration of L-cysteine to our active cell-free system from E.coli and 
indeed Ifuku et al.91a) have also observed that L-cysteine had no effect on 
the amount of biotin formed. 
A major drawback in our identification of putative sulphur donors was 
the inability of the DH1iJpIMSB cell-free extract to withstand dialysis. 
Incubation of dialysed DH1iIpIMSB cell-free extract with NADPH, 
AdoMet, KC1, Fe2 , L-cysteine and D-DTB showed no biotin-forming 
activity indicating that a necessary cofactor(s)/protein was lost or 
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inactivated upon dialysis with buffer. This phenomenon has also been 
observed by Ifuku et al.91a). In preliminary experiments they found that 
ammonium sulphate fractionation (0-90%) of their cell-free extract 
resulted in loss of activity. Marquet et al. have also observed this loss in 
activity upon dialysis of cell-free extracts of B.sphaericus9th) and E.coli94. 
Despite this, radiolabel incorporation experiments have implicated a role 
for L-cysteine in sulphur donation in the biotin synthase reaction. 
Incorporation of 35S-label into biotin has been observed upon incubation 
of 35S-L-cysteine in the presence of other cofactors in cell-free extracts of 
B.sphaericus92 and E.coli. However it should be noted that the specific 
activity of the [35S]-D-biotin produced from [35S]-L-cysteine is much lower 
than that predicted on the basis of direct incorporation of label from the 
substrate into biotin indicating that some dilution of the radiolabel occurs 
in the experiment. The most obvious factor contributing to this 
observation is simply that the radiolabelled cysteine is diluted by 
unlabelled amino acid entrained in the incubation mixtures. 
Indeed quantitative amino acid analysis of the supernatant of 
DH1iIpIMSB after protein denaturation indicated approximately 400M 
of L-cysteine was present. 
In order to gain an insight into the mechanism of sulphur donation, we 
incubated [14C]-L-cysteine with an aliquot of DH11IpIMSB cell-free 
extract and monitored the fate of the radioactive amino acid. This was 
achieved by separation of the constituent amino acids by High Voltage 
Paper Electrophoresis (HYPE) at 3kV and pH 2.0. Under these 
conditions, the sole radioactive product was [14C]-L-alanine. Similar 
results were obtained in control incubations with cell-free extracts 
lacking the bioB gene product, implying the desulphurisation of [14C]-L-
cysteine is not a consequence of bioB gene product activity. The results of 
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Fig.3.5 Plot of 14C-alanine formation against time. 
The desuiphurisation of L-cysteine to L-alanine is not without enzymic 
precedent. The nifs gene product (NIFS) of Azotobacter vinelandii is a 
pyridoxal phosphate-dependent homodimer (88kDa) that catalyses the 
desuiphurisation of L-cysteine to yield L-alanine and sulphur148. This 
activity is required for the full activation of the two metalloproteins that 
are the components of nitrogenase. (The role of nitrogenase in biological 
nitrogen fixation has been extensively reviewed149.) 
These components, Fe protein and MoFe protein, both contain 
metalloclusters which are required for their respective activities and it is 
suggested that NIFS participates in the biosynthesis of the nitrogenase 
metalloclusters by providing the inorganic sulphur required for Fe-S core 
formation. Dean et al.150 have suggested NIFS catalyses the formation of 
an enzyme-bound persuiphide which is the active species for providing 
the inorganic sulphur necessary for Fe-S cluster biosynthesis and 
experimental evidence has led to the proposed mechanism for the 
desulphurisation of L-cysteine catalysed by NIFS shown in Scheme 3.1 
The salient and novel feature of this mechanism is nucleophiic attack by 
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Scheme 3.1 Proposed mechanism of NIFS desuiphuration reaction 
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adduct which results in formation of a cysteinyl persuiphide and an 
enamine derivavtive of L-alanine. 	Site-directed mutagenesis 
experiments, which show that cys325 is required for cysteine 
desuiphurase activity, support this mechanism. 
Olefinic amino acids are often utilised as mechanism-based suicide 
inhibitors of PLP-dependent enzymes15' so we used L-allylglycine to 
investigate the mechanism of cysteine desuiphurisation in E.coli. 
Aliquots of DH1i/pIMSB cell-free extract were incubated with various 
concentrations of L-allylglycine (0, 5, 10, 20 amd 50mM). After dialysis to 
remove excess L-allylglycine, each aliquot was incubated with [14C]-L-
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Fig.3.6 Inhibition of E.coli cysteine desuiphurase activity by L-allylglycine 
The observed loss in cysteine desulphurase activity was not reversed by 
the addition of L-cysteine and PLP suggesting L-allylglycine inactivates 
the enzyme irreversibly. 
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These results imply the E.coli enzyme catalysing the desuiphurisation of 
L-cysteine to L-alanine and sulphur is pyridoxal phosphate-dependent. 
Dean et al. have examined the mechanism-based suicide inhibition of 
NIFS by L-allylglycine in detail and their results150 have led to the 
proposed mechanism shown in Scheme 3.2. This route involves a 
mechanism-based suicide inactivation in which the enzyme tautomerises 
the terminal double bond of L-allylglycine followed by nucleophilic attack 
by the proposed active cysteinyl residue at the y-carbon. This mechanism 
has precedence in cystathionine y-synthase which catalyses the formation 
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Scheme 3.2 Proposed mechanism of inhibition of NIFS by L-allylglycine 
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3.3 The Purification of E.coli cysteine desuiphurase 
After demonstrating cysteine desuiphurase activity in cell-free extracts of 
both DH1i/pIMSB and pCOi we hoped to proceed by purifying the 
cysteine desuiphurase to homogeneity and establish if this enzyme was 
involved in the biotin synthase reaction. The use of racliolabelled 
substrate would ensure the detection of small amounts of protein from 
the various chromatographic purification procedures employed. 
Ammonium sulphate fractionation of DH11JpIMSB cell-free extract was 
performed and the proteins precipitating between 20 and 50% saturation 
exhibited cysteine deulphurase activity. The 20-50% ammonium 
sulphate fraction was dialysed to remove the salt and applied to a DEAE-
cellulose anion exchange column. The column was washed with Tris 
buffer (50mM, pH7.5) and the proteins eluted with a linear salt gradient 
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Fig.3.7 DEAE-cellulose anion exchange chromatography of 20-50% ammonium 
sulphate fraction of DH1iJpIMSB cell-free extract. Fractions were assayed for 
cysteine desulphurase activity under standard [14C]-L-cysteine assay conditions. 
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E.coli cysteine desuiphurase eluted between 200 and 300mM salt 
concentration. Active fractions were pooled, concentrated and dialysed 
against Tris buffer (50mM, pH 7.5) to remove salt. 
The concentrated sample was subjected to further anion exchange 
chromatography on Mono Q resin using FPLC. Bound proteins were 
eluted with a linear salt gradient (0-500mM) to yield the 
chromatographic trace shown in Fig.3.8 
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Fig.3.8 MonoQ-sepharose anion exchange chromatography of pooled active 
fractions from DEAE column. Fractions were analysed for cysteine 
desuiphurase activity under standard [14C]-L-cysteine assay conditions. 
Active cysteine desuiphurase eluted between 380 and 400mM NaCl 
concentration. 
The specific activity of E.coli cysteine desuiphurase was monitored at 
each stage of the purification (Fig.3.9) and protein content was analysed 
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This analysis showed the acculmulation of two major soluble polypeptides 
A and B of approximate molecular weight 55 and 90 kDa respectively. 
SDS-PAGE of peak 2 from the chromatographic separation of proteins on 
the Mono Q anion exchange column showed that the major band was the 
55kDa protein. This fraction displayed significantly lower cysteine 
desulphurase activity on comparison with the fractions from peak 1. 
From this, the 90kDa protein was tentatively assigned as E.coli cysteine 
desulphurase. 
Incubation of DH1iJpIMSB cell-free extract with the MonoQ protein 
concentrate and the necessary cofactors did not result in an increase in 
biotin-forming activity. This suggests that either cysteine desulphurase 
is not intimately involved in the biotin synthase reaction or that other 
unidentified factors in the reaction are rate-limiting. It is clear that an 
active purified system is neccesary before the individual stages in this 
enzymic transformation can be elucidated. 
However, a role for cysteine desulphurase in the biotin synthase reaction 
can be justified by considering a number of observations already 
encountered. 
Incorporation experiments with bioB transformants of both E.coli93 and 
B.sphaericus92 have shown the production of labelled biotin upon 
incubation with [35S]-L-cysteine. Previous studies have indicated that the 
sulphide present in iron-sulphur proteins from E.coli likely originates 
from cysteine sulphur153. Also, Takahashi et al. have observed 
incorporation of radiolabel from [35S]-L-cysteine into the Fe-S cluster of 
[2Fe-2S] ferredoxin from spinach chioroplasts 154 
EPR studies on purified bioB gene product indicates that the [2Fe-2S] 
cluster is highly unstable in the reduced state'19. The possibility that the 
sulphur added to dethiobiotin comes from the Fe-S cluster may suggest 
that its instability is associated with the loss of sulphur from the cluster 
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during catalysis. If the sulphur does come from the cluster, then an 
integral part in enzyme turnover would be cluster resynthesis. 
By analogy with the nitS gene product, it is plausible that E.coli cysteine 
desulphurase is involved in the synthesis of bioB gene product Fe-S 
cluster. 
Important progress has been made over recent years in the field of iron-
sulphur proteins155 but little is still known about the assembly of iron-
sulphur clusters within the cell and their insertion into the various 
apoproteins. Attempts to reconstitute several iron-sulphur proteins by 
chemical methods have been more or less successful156 but because of the 
toxic nature of the reagents employed157 and the non-specific chemical 
reactions158 involved, the physiological relevance of such models is 
doubtful. 
Evidence has been reported on the possible involvement of 
sulphurtransferases in the biosynthesis of iron-sulphur clusters. 3-
Mercaptopyruvate sulphurtransferase activity was observed in both 
mitochondria and cytosol, but its involvement in the in vitro formation of 
the iron-sulphur cluster of adrenodoxin requires cysteine transaminase 
activity which is only present in the cytoso1159. Rhodanese (thiosulphate-
cyanide sulphurtransferase) activity has been detected in mitochondrial 
fractions and has been implicated in metallocluster biosynthesis by its 
ability to reconstitute the chromophore of apoferredoxin in vitro160. 
However, the role of rhodanese in Fe-S cluster formation has been argued 
against because rhodanese has not been detected in appreciable levels in 
certain bacteria known to contain nonheme iron-sulphur proteins. 
Moreover, any enzyme that catalyses the formation of sulphide could be 
expected to assist reconstitution of apoproteins in vitro because such 
reconstitution occurs spontaneously, provided that sufficient sulphide and 
iron are available'6' 
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Genes present in nonnitrogen fixing organisms such as Lactobacillus 
delbrueckii162, Bacillus subtilis163, Saccharomyces cerevisiae162 and 
Candida maltosa'62 have been shown to have extraordinary sequence 
identity when compared to ni/S. Although the specific functions of the 
ni/S-like genes from these organisms are not yet established, the results 
shown here support the view that cysteine desulphurase activity may 
represent a universal mechanism for the activation of sulphur required 
for metallocluster biosynthesis. 
3.4 Conclusion 
Upon establishing an active in vitro system for the conversion of 
dethiobiotin to biotin, the mechanism of sulphur donation was 
investigated. [14C]-L-cysteine was found to be converted to [14C]L 
alanine upon incubation with DH1i/pIMSB cell-free extract. Enzymatic 
inhibition of [14C]-alanine formation with L-allylglycine suggests the 
enzyme responsible for this transformation uses PLP chemistry in its 
action. 
Partial purification of the E.coli cysteine desulphurase and analysis by 
SDS-PAGE showed the accumulation of two soluble polypeptides of 
molecular weight 55 and 90kDa . The latter protein was thought to be 
the cysteine desulphurase on the basis that purified extracts containly 
mostly 55kDa protein exhibited significantly less desulphurase activity. 
This previously unreported enzyme has precedent in cysteine 
desulphurase from Azotobacter vinelandii which is thought to be involved 
in nitrogenase metallocluster biosynthesis. 
Although it is unknown whether E.coli cysteine desulphurase is involved 
in the bioconversion of dethiobiotin to biotin, analogy with the ni/S gene 
product and the discovery of ni/S-like genes from other nonnitrogen fixing 
organisms suggest that this enzyme may be involved in the sequestering 
of sulphur required for Fe-S cluster formation in metalloproteins. 
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Chapter 4 
The Mechanism of Biotin Synthase- 




The final step in the biosynthesis of biotin, which involves the insertion of 
sulphur into the saturated C-H bonds at C-6 and C-9 of dethiobiotin, is 
perhaps the most interesting and unusual stage in the synthesis of the 
coenzyme. The lack of chemical precedent and hence the mechanistic 
novelty of this transformation has stimulated an active area of research. 
Recent investigations in E.coli115  and B.sphaericus"6 have implicated an 
intermediary role for 9-mercaptodethiobiotin 25 in the biosynthesis of 
biotin (Scheme 4.1) and feeding studies"8 with [3H]-pimelic acid in 
Lavandula vera resulted in the formation of a compound which co-
chromatographed with an authentic sample of 9-mercaptodethiobiotin. 
However, this putative precursor has yet to be isolated and characterised 
in bacterial cell extracts. 
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One of the aims of this thesis was to investigate the mechanistic aspects of 
biotin biosynthesis in vitro through the synthesis of substrate analogues of 
dethiobiotin specifically labelled at the C-6 position. 
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Administration of these aberrant analogues to bioB transformants should 
retard abstration at C-6 and inhibit ring closure (Scheme 4.2). 
Identification of the enzymic products of these slow arrest/trapping 
experiments would hopefully provide an insight into the mechanism 
associated with this transformation. 
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Scheme 4.2 
The scope of these analogues is not only restricted to mechanistic studies. 
Biotin is essential for the production of cell membrane lipids in all 
organisms and is synthesised in limited amounts by plants and 
microorganisms but not animals. Thus analogues of biotin biosynthetic 
precursors which inhibit the enzymes of its biosynthesis should have 
potential value as microbial and agrochemical biocides. Some derivatives 
of biotin precursors have already been shown to exhibit anti-microbial 
activity (Fig.4.1). 
a -Dehydrodethiobiotin 58 represses transcription of both 1 and r strands 
of the biotin operon'64165 while homobiotin 59 and a-methylbiotin 60 also 
exhibit weak co-ordinate repression of transcription 165. Their mode of 
action appears to be as pseudo-substrates of birA where they function as 
corepressors of bio gene expression. 
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Fig. 4.1 Anti-metabolites of biotin biosynthesis 
4.1 The Synthesis of [6,9-2H2]- (+)-dethiobiotin. 
The use of Raney nickel in the hydrodesulphurisation of sulphur 
compounds is well documentedl€é and was employed in the structure 
elucidation of biotin by du Vigneaud et al.25 The desuiphurisation 
process proceeds with retention of configuration at both chiral centres in 
dethiobiotin. Despite extensive research'6 , the mechanism of 











Fig. 4.2 The deuterodesuiphurisation of (+)-biotin methyl ester 
Initial studies began with the synthesis of [6,9-2H2]-dethiobiotin 61 from 
biotin using [2H]-Raney nickel (Fig.4.2). Preparation of the deuterated 
catalyst was achieved by the method of Mozingo"' using nickel- 
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aluminium alloy and sodium deuteroxide in D20. Analysis of the labelled 
product by 'H nmr (360 MHz) revealed, on comparison with dethiobiotin, 
a change in the C-9 methyl, C-6 methylene and bridgehead H-7 and H-8 
multiplicity. On insertion of deuterium at C-9, the two hydrogen atoms of 
the methylene group become stereochemically non-equivalent. A change 
in the complexity and integral was also observed in the unresolved 
multiplet at 6 1.46-1.54 indicating the introduction of deuterium at C-6. 
The deuterodesulphurisation of biotin also resulted in changes in the 
multiplicities of the H-7 and H-8 methine resonances.. 
Spin decoupling experiments augmented these initial observations. 
Irradiation of the H-8 methine resonance resulted in collapse of the H-7 
methine signal at 6 3.77 to a doublet. This was accompanied by collapse 
of the C-9 methylene signal to a singlet. The presence of an additional 
resonance observed as a shoulder on the C-9 CH2 signal indicated 
however that the methylene group might be diastereotopic. Irradiation of 
the H-7 methine signal led to collapse of the H-8 methine multiplet at 8 
3.90 to an unresolved multiplet and small changes in the multiplet of the 
C-3 and C-6 methylene resonances at 6 1.46-1.60. The 13C DEPT 
spectrum provided additional evidence for the introduction of two 
deuterium atoms at C-6 and C-9 of dethiobiotin (Fig.4.3). Spectral 
comparison with dethiobiotin (a) revealed the disappearance of the 
positive C-9 methyl singlet at 6 14.16 and the appearance of a negative 
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Fig.4.3 'C DEPT (311/4) nmr spectra of a) dethiobiotin and b) [6,9-2H2]-
dethiobiotin 
The shift to lower frequency in the C-6 signal of [6,9 2H2]dethiobiotin is 
the result of a deuterium isotope effect. As observed, the a-shift is in the 
order of 0.27ppm per deuterium and 0.1 ppm for the n-shift. The 
appearance of a positive triplet resonance at 27.86 ppm verified the 
introduction of deuterium at C-6. 
Analysis of the 2H-nmr spectrum of 61 gave supporting evidence for the 
regiospecific incorporation of the label. Strong resonances at 6 1.04 and 6 
1.50 indicated the direct introduction of deuterium atoms into C-9 and C-6 
respectively. The smaller signals at 6 3.89 and 6 3.78 can be attributed to 
bridgehead proton exchange. The latter signal was of lower intensity to 
that of the H-8 resonance and the lower incorporation of 2H at C-7 is 
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Fig 4.4. Deuterodesuiphurisation of (+)-biotin methyl ester with A 
retention/inversion or B loss of chirality 
Further 1H nmr analysis was required to establish whether chirality was 
retained at C-6 after deuterodesuiphurisation of biotin. 
Since the methylene protons at C-6 in dethiobiotin are diasterotopic, we 
would expect the individual proton resonances to occur at different 
chemical shifts. Analysis of proton dispersion, signal and integral 
intensity of the labelled compound, in conjunction with spin decoupling 
experiments, should indicate whether retention of chirality, inversion or 
racemisation has occurred at that site (Fig.4.4). 
Initial 'H nmr studies on dethiobiotin methyl ester at 200MHz showed no 
clear dispersion of the C-6 methylene protons. The methylene signals of 
interest were hidden under the unresolved multiplet at 6 1.44-1.60 so a 
variety of lanthanide shift reagent (LSR) titration experiments were 
performed. 
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Fig.4.5 'H nmr spectrum of titration of Pr(FOD)3 with dethiobiotin methyl 
ester 
Titration of Pr(FOD)3  with dethiobiotin methyl ester did produce a shift 
effect in the correct region of the spectrum however the accompanying 
line broadening prevented the use of spin-decoupling for proton 
assignment (Fig.4.5). 
Distinction between the 6-proS and 6-proR signals in the spectrum of 61 
was however apparent at 600MHz. Low resolution COSY of the aliphatic 
region (6 0-4.3) displayed a cross peak at 6 1.49 which corresponded to a 
coupling assignment between the H-7 bridgehead proton (6 3.70) and the 
C-6 methine proton. Examination of unlabelled dethiobiotin methyl ester 
revealed resolution in the region 6 1.42-1.54 (Fig.4.6) with two proton 
integration and this multiplet was attributed to the C-6 methylene group. 
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Fig. 4.6 'H nmr spectrum of (-f)-dethiobiotin methyl ester at 600MHz 
Fig. 4.7 1H nmr spectrum of [6,92H2](+)dethiobiotifl methyl ester at 600 MHz 
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On examination of the 1H nmr spectrum of [6,9-2H2]-dethiobiotin methyl 
ester (Fig.4.7) the multiplet at ö 1.42-1.52 was found to be of reduced 
intensity and both regions of this multiplet integrated for approximately 
0.5H. This observation indicated racemisation at C-6 had occurred and so 
excluded the use of this compound in future biological experiments. 
4.2 Approaches towards the synthesis of 16,6-2H21- and [6,6-F2]-(±)-
dethiobiotins 
The lack of stereospecificity in the introduction of deuterium at C-6 of 
dethiobiotin using 2H-Raney nickel suggested that a better approach 
would be to construct dethiobiotin precursors geminally labelled at the 6 
position. Introduction of two 2H's at C-6 would circumvent any problems 
of racemisation in the synthesis. Additionally, the 6,6-dideutero- and 
6,6-difluorodethiobiotins were targetted for synthesis. 
The latter analogue is of particular relevance since fluorinated 
derivatives of biological molecules frequently have dramatic effects on 
enzymatic reactions. The van der Waals radius of the fluorine atom 
(1.35A) is closest to that of the hydrogen atom (1.20A) while the C-F and 
C-H bond lengths (1.26-1.41A compared to 1.08-1.11A) are approximately 
the same. The substitution of fluorine for hydrogen does not dramatically 
alter the steric environment in the molecule thus allowing fluorinated 
precursors to mimic the metabolic fate of the parent hydrogen 
compounds'. The increase in bond strength associated with the 
substitution of hydrogen for fluorine creates a substrate resistant to 
metabolic transformations which require manipulation of the C-F bond170 
The large difference in electronegativity between fluorine (4.0) and 
hydrogen (2.1) translates into a substantial elctronic effect on nearby 
carbon èentres. In addition, C-F bonds substantially increase the 
89 
lipophilicities of fluorinated precursor analogues. The combination of 
these effects has firmly established the use of fluorine-containing 
analogues of biological intermediates in the pharmaceutical and 
agrochemical industry. 
Biotin and its derivatives have provided an attractive target for total 
synthesis. The first total synthesis of biotin was acheived by Harris et 
al.6  and since then a large number of syntheses have been reported by 
numerous research groups". 
Novel synthetic approaches have included the use of carbohydrate '7 , 
aromatic172 and aliphatic173 precursors while photochemical174 and 
cycloaddition175 methodology has been utilised to maintain 
enantioselectivity at biotin's 3 chiral centres. However , few of these 
approaches are applicable to synthesis requiring label incorporation at C-
6 of dethiobiotin. 
Retrosynthetic analysis of the proposed compounds suggested they should 
be available through manipulation of the 6-keto moeity of 62.(Fig.4.8) 
This product is available from a Friedel-Crafts acylation of 4-methyl-4-
imidazolin-2-one 39. 
0 0 
HNANH 	 HNANH 
CO2H 
CO2Et 
0 x 	 62 
56 X=D 
57X=F 	 0 
H N 	NH 
CI C 02  E 
0 
39 
Fig.4.8 Retrosynthetic analysis of target compounds 
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Previous routes'76 to 4-methyl-4-imidazolin-2-one have utilised ethyl 
acetoacetate 63 as the starting material (Scheme 4.3). The route 
proceeds through fomation of the a-oxime of ethyl acetoacetate 64 by the 
addition of sodium nitrite in glacial acetic acid. Catalytic hydrogenation 
to the intermediate amine 65, and treatment with an acidic solution of 
potassium isocyanate affords the cycised product 4-methyl-5-
ethoxycarbonyl-2-imidazolinone 66. Subsequent saponification and 
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Scheme 4.3 
The construction of the ureido ring skeleton by this procedure appeared 
time-consuming and necessitated refinement. 	Interest177 in the 
cardiotonic properties of 4-methyl-(5-substituted benzoyl)-imidazolin-2-
one derivatives has resulted in a recent one-step synthesis of 4-methyl-4-
imidazolin-2-one by Andrews13' and this procedure was employed here. 
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The condensation of acetol 37 and urea 36 in glacial acetic acid gave a 
dark coloured residue which, on extraction and crystallisation from 
water, afforded the cydised product 4-methyl-4-imidazolin-2-one 39 in 
25% yield. 
Friedel-Crafts acylation of 39 with ethyl 5-chioroformyl pentanoate 67 
using the method of Duschinsky and Do1an17 gave 6-keto-
dehydrodethiobiotin ethyl ester 62 in 52% from the starting 
imidazolinone. 
Duschinsky and Do1an17 have investigated the hydrogenation of 62 to 
dethiobiotin ethyl ester and found two distinct steps in the reduction of 
the a,13-unsaturated ketone. 	Hydrogenation of 6-keto- 
dehydrodethiobiotin ethyl ester with Adams catalyst (Pt02) resulted in 
rapid uptake of 2 moles of hydrogen and reduction of the 6-keto moeity to 
a methylene group. This was confirmed through' the isolation of 
dehydrodethiobiotin ethyl ester. A third mole of hydrogen was consumed 
more slowly to give dethiobiotin ethyl ester in good yield. 
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We reasoned that the reduction of the 6-keto group could be performed 
with deuterium in place of hydrogen and this would provide a rapid and 
effective method for introduction of a geminal label into the 6-position of 
dethiobiotin. 
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Fig. 4.9 Deuterogenolysis of 6-keto-dehydrodethiobiotin ethyl ester 
The reduction of 6-keto-dehydrodethiobiotin ethyl ester was accomplished 
over pre-reduced Adams catalyst in glacial acetic acid under an 
atmosphere of deuterium at 250C.  After 3 hours, two molar equivalents 
of deuterium had been consumed and crystallisation from ethanol 
afforded a white microcrystalline solid which co-chromatographed with 
authentic 68. 
The 13C DEPT nmr spectrum of this product displayed signals at 116.92 
and 112.59 ppm corresponding to the vinyl carbons at C-8 and C-7 
respectively. This indicated the imidazolinone double bond remained 
unreduced. However the disappearance of the a,13-unsaturated  carbonyl 
resonance at 188.4 ppm, which was associated with reduction of the 6-
keto group, resulted in the appearance of a methylene signal at 33.11 
ppm. This indicated the formation of undeuterated dehydrodethiobiotin 
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ethyl ester 68 and this was attributed to the use of non-deuterated 
solvent in the reaction (Fig.4.9). 
The reaction was repeated in d-acetic acid under similar conditions and 
the product isolated upon the uptake of moles of two moles of deuterium. 
However, the spectral properties of the reduced material proved 
anomalous. 1H nmr of the product revealed the disappearance of the 
singlet at 8 2.02 associated with the allylic methyl at C-9. Moreover, the 
multiplet at 8 1.67, attributed to the resonance of 4 methylene protons 
from the aliphatic side chain, only integrated for 2.5 protons. The 
presence of the imidazolinone double bond and reduction of the ketone 
was confimed by 'C DEPT nmr but of the 5 methylene signals in the 
spectrum, the resonances at 27.85 ppm and 27.96 ppm were of reduced 
intensity relative to those of dehydrodethiobiotin ethyl ester. These 
preliminary observations suggested deuterogenolysis of the 6-keto group 
was successful but involved complete exchange of the C-9 methyl protons 
and partial exchange of the side chain protons as a consequence (Fig.2.9). 
nmr and FAB mass spectrometry supported this non-specific 
distribution of deuterium and this method of label incorporation was 
abandoned in the hope a more regiospecific alternative could be found. 
Attention was turned to the preparation of 6,6-difluorodethiobiotin. The 
gem-difluoro group is prepared, most frequently, from the corresponding 
ketone or aldehyde. However, this approach is often limited by the 
inconvenience of obtaining and using the reagents required for this 
conversion. Sulphur tetrafluoride with 'hydrogen fluoride as a catalyst, 
the classical method for achieving this transformation', generally 
provides good yields of the desired product, but its use requires extreme 
caution because of its toxicity, reactivity and volatility. Pressure 
equipment constructed from fluorine-resistant material such as stainless 
steel bombs must be used180, and high temperatures are frequently 
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necessary. Diethylaminosulphur trifluoride (DAST) has provided a 
milder alternative to SF4 as a fluorinating agent'81. 
Attempted conversion of 6-keto-dehydrodethiobiotin ethyl ester into the 
corresponding difluoromethylene compound with DAST was unsuccessful 
under a variety of conditions (up to 48 hours in neat DAST at reflux) 
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Scheme 4.5 
Sondej and Katzenellenbogen182 have reported that gem-difluoro 
compounds can be prepared from ketones by formation of the 
corresponding 1, 3-dithiolane, followed by reaction with 1, 3-dibromo-5, 5-
dimethylhydantoin and pyridinium poly(hydrogen fluoride). 
Reaction of 62 with 1, 2 -ethane dithiol and boron trifluoride etherate as 
Lewis acid gave 6-dithioketal-dehydrodethiobiotin ethyl ester 71 in 85% 
yield. Reaction of this compound with pyridinium poly(hydrogen fluoride) 
and a variety of N-halo oxidants resulted in consumption of starting 
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material but analysis of the reaction products by 19F nmr revealed no 
incorporation of fluorine into the molecule. Most fluorinations in the 
literature utilising carbonyl transformation chemistry involve isolated 
ketones which may be more electrophilic towards fluoride attack than the 
conjugated systems in 62 and 71. 
It has been shown that derivatisation of the imidazolinone nitrogens can 
render the double bond susceptible to selective hydrogenation with 
respect to the 6-keto functionality110. Acetylation of 62 with acetic 
anhydride and crystallisation from aqueous ethanol yielded 6-keto-N,N'-
diacetyl-dehydrodethiobiotin ethyl ester 72 in 82% yield. Catalytic 
hydrogenation of 72 at room temperature and pressure over 10% 
palladium on charcoal in 1,4-dioxan produced a mixture of cis and trans 
6-keto-N,N'-diacetyl-(±)-dethiobiotin ethyl esters (82:18) 73 and 74 which 
were separated by dry flash chromatography. (Scheme 4.6) 
'H nmr analysis of the cis ketone 73 showed the doublet of the H-7 proton 
was shifted to higher frequency by 0.5 ppm relative to that of the trans 
isomer and displayed the expected larger cis coupling constant of 9.8 Hz. 
The coupling constant between the 9-methyl group and the H-8 methine 
proton (J9,8=6.5Hz) is similar in both 73 and 74. 
Perversely 6-keto-N, N-diacetyl- (±)-dethiobiotin ethyl ester was also 
resistant to fluorination with DAST and attempts at dithioketalisation 
proved abortive. The reluctance of 73 to form the corresponding 6-
dithioketal compound can be attributed to the N-acetyl group which can 
sterically hinder the 6-keto moeity and prevent reaction. However, 
removal of the acetyl groups to decrease this interaction was not practical 
since deacetylation with acid or base resulted in epimerisation at C-7 of 
73 to give the more thermodynamically stable trans isomer 76. However, 
Marquet"° had noted that the reduction of the ketohe 73 with NaBH4 to 
afford the N,N'-diacetyl alcohol also gave the N-acetyl alcohol 75 as a side 
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product so we decided to use this procedure as a method of selective 
deacetylation. Optimisation of the reaction conditions gave only the N-
acetyl alcohol, 6-(R,S)-hydroxy-N-acetyl-(±)-d.ethiobiotjn ethyl ester 75, as 
the principal product (Scheme 4.6). 
Surprisingly, attempts to convert the secondary alcohol into the 
corresponding ketone even with strong oxidising agents such as Jones 
reagent, KMn04 and Mn02 proved futile. The compound was equally 
resistant to conversion to the monofluoro derivative with DAST. Model 
studies183  indicate that strong NH-OH intramolecular hydrogen bonding 
can occur in 75. The broad absorptions at 3460 and 3240 cm-' in the JR 
spectrum of this compound and its resistance to oxidation imply that such 
may be the case. To test the rationale behind these observations we 
removed the acetyl groups from 73 with sodium ethoxide and this 
resulted in the expected epimerisation at C-7 to yield 6-keto- trans- (±)-
dethiobiotin ethyl ester 76. This was easily converted to its dithioketal 
derivative 77 by treatment with 1,2-ethanedithiol and BF3.Et2O. 
Although unreactive to oxidative fluorodesuiphurisation using the 
conditions described earlier, this compound underwent 
deuterodesuiphurisation using [2H]-Raney nickel resulting in formation of 
[6,6-2H2]- trans- (±)-dethjobiotjn ethyl ester 78. The structure of 78 was 
confirmed by 'H and 'C DEPT nmr in conjunction with FAB mass 
spectrometry. 
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Both [6, 6..2H2] -(±)-dethiobiotin and [6,6-F2] -(±)-dethiobiotin have proved 
difficult targets for synthesis using the methodology adopted here. The 
synthesis of labelled dethiobiotin using deuterated Raney nickel and the 
observation that the introduction of deuterium involves racemisation at 
C-6 of dethiobiotin supports the current hypothesis that Raney nickel 
reactions, although still in doubt, probably occur by a free-radical 
mechanism184. 
It is clear from these studies that carbonyl transformation chemistry is 
not suited for the introduction of fluorine into these molecules while non-
specific distribution of label or epimerisation has impeded formation of 
labelled dethiobiotin with the correct sterochemistry for biological 
evaluation. Alternative strategies which can circumvent these problems 
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5.0 Addendum and Suggestions for Future Work 
After completion of this work, Birch and her co-workers at Lonza AG 
reported their investigation into the low molecular weight and protein 
components required for in vitro activity of the biotin synthase complex 
from E.co1i185. They found that cofactor requirements included NADPH, 
Fe2 , AdoMet, L-cysteine and high concentrations of one of the amino 
acids asparagine, aspartate, glutamine or serine. They also found that an 
unidentified thiamine pyrophosphate (TPP)-dependent protein is required 
in addition to the bioB gene product, flavodoxin and ferredoxin 
(flavodoxin) NADP reductase for activity. The role of TPP and the amino 
acids other than cysteine is unknown. The role of TPP is noteworthy 
since TPP is normally associated with decarboxylation of a-ketoacids (e.g 
pyruvate in pyruvate dehydrogenase, pyruvate decarboxylase and 
acetolactate synthase). TPP seems to be required to maintain the activity 
of one of the proteins involved in the biotin synthase reaction although 
the proteins function is unknown. Here, it may be that TPP acts as an 
allosteric agent for one of the enzymes involved in the reaction. For 
optimal activity in the assays in vitro, the amino acids are required at 
concentrations above those naturally found in E.coli cells, and Birch et al. 
suggest that they may be directly involved in the reaction in vitro, or may 
have a regulator role. 
An alternative argument could be that high concentrations of an amino 
acid help to protect the protein complex either specifically (through an 
allosteric effect) or merely as a buffer component. 
Future work must involve the purification of E.coli cysteine desulphurase 
and determining its role (if any) in the biotin synthase reaction. Location 
and sequencing of the gene encoding this protein may provide an insight 
into its function in E.coli and perhaps its existence in other non-nitrogen 
fixing organisms. It is interesting to speculate whether TPP acts 
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allosterically and it should be relatively easy to determine if E.coli 
cysteine desuiphurase and the TPP-dependant protein described above 
are one and the same. 
The synthesis and charactérisation of the modified DAPA analogues has 
now allowed the enzymatic synthesis of radiolabelled dethiobiotin 
analogues with DTBS and H1 CO3- to be performed. This should 
ascertain whether sulphur introduction is affected by chain length in the 
biotin synthase reaction. 
The dideutero- and difluorodethiobiotins have strong applications as 
selective biocides and further research into this area may lead to their 
eventual synthesis. 
The current evidence suggests that biotin synthase can be included in a 
growing section of enzymes catalysing reactions by a radical process. 
However, it is clear we still in the early stages of understanding this 
unique transformation and only through the complete purification and 
characterisation of all the components of the biotin synthase system can 





All starting materials were purchased from commercial sources (Sigma-
Aldrich Inc., Fluka and Lancaster Synthesis unless otherwise stated) and 
used without further purification. All solvents used in chemical reactions 
were dried and distilled before use. Diazomethane was prepared as an 
ethereal solution fron Diazald by the procedure of De Boer and Backer196 
Merck silica 60 (70-230 mesh) was used for column chromatography and 
thin layer chromatography (tic) was carried out on 200 x 200 x 0.2mm 
layers of Merck 60F254 silica. Components were visualised by UV, 
phosphomolybdic acid spray reagent or by exposure to iodine vapour. 
Biotin and its derivatives were identified on tic by colour reaction with 
0.2% N, N-dimethylaminocinnamaldehyde in 2% cone. sulphuric 
acid/ethanol'92. Melting points were determined on a Reichert 7905 hot-
stage apparatus and are uncorrected. JR spectra were recorded on a 
Biorad SP3200 FTIR spectrophotometer. Samples were prepared as 
liquid films or as nujol mulls unless otherwise stated. NMR spectra were 
recorded on Jeol PMX60, Bruker WP80, WP200, AX250, WM360 and 
Varian VXR600S spectrometers using tetramethylsilane (80.0) as an 
external standard. Coupling constants (J) are given in Hz. Fast Atom 
Bombardment (FAB) mass spectra were measured using a Kratos MS 50 
TC spectrometer and were carried out using either glycerol or thioglycerol 
as sample matrices.. Elemental analyses were determined using a Perkin 
Elmer 2400 elemental analyser. Radioactivity was determined as counts 
per minute (cpm) on a LKB 1212 RackBeta liquid scintillation counter 
using Optiphase Hi-Safe 3 liquid scintilant and 14C-hexadecane 
(306.1dpm mg-1) as an external standard. Sonication was performed 
using an M.S.E Soniprep 150 ultrasonic disintegrator. Protein gel 
electrophoresis was performed using a Bio-Rad Protein II apparatus 
(Hercules, CF, USA) 
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Biotin Methyl Ester la 
D-Biotin 1 (1.51g, 5.1mmol) was slurried in methanol (20m1). An ethereal 
solution of diazomethane was added until a green/yellow colour persisted. 
The ether was removed in vacuo to afford a white solid. Analysis by tic ( 
silica, methanol/chloroform (1:20)) indicated the reaction had gone to 
completion . Recrystallisation from methanol yielded biotin methyl ester 
(1.33g, 83%) as a white needles, m.p. 165-167°C (lit.5 165-167°C); 
2H-Raney Nickel 
A solution of sodium deuteroxide (4g, 0.098mol) in D20 (8m1) was placed 
in a beaker, stirring magnetically and cooled in an ice-bath to 10°C. 
Nickel-aluminium alloy (2g) was added in small portions with stirring so 
that the temperature did not rise above 20°C. The mixture was removed 
from ice and allowed to attain room temperature. The contents were then 
stirred until evolution of gas became slow (-'5 hours). The supernatant 
liquid was then decanted and the nickel washed with D20 until neutral 
pH. The nickel was transferred to a dry sample bottle and stored under 
99.8 atom% D20. 
[6,9-2H21-(+)-dethiobiotin 61 
Biotin methyl ester la (100mg, 0.39mmol) was dissolved in d4-methanol 
(4ml) and heated under reflux with [2H]-Raney nickel (imi, -'0.6g W-2 
suspension in D20, pH12) for 1 hour. 	Tic (silica, 20% 
methanol/chloroform) of the reaction mixture indicated the reaction had 
gone to completion. The reaction mixture was filtered and the nickel 
washed with water (15m1). The filtrate and combined washings were 
acidified to pH4 with acetic acid and passed through an AG50 H (x8) 
cation exchange column. Ethanol (12m1) was added to the eluate and the 
solvent removed in vacuo to give [6,9-2H2]-(±)-deth1'Lobiotin  61 (43mg, 
51%), 8H (D20, 360MHz) 3.88 (1 H, in, H-8), 3.77 (1 H, m, H-7), 2.16 (2 H, 
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t, J7.4, -CH2-0O2H), 1.46-1.60 (3 H, m), 1.28-1.40 (4 H,m), 1.09 (2 H, in, 
J6.0, DCH2-) ppm; 8c (D20, DEPT) 55.82, 51.31, 37.33, 28.38, 27.85, 
25.52, 25.10 and 13.89 ppm; 61) (H20) 3.89, 3.78, 2.16,1.50, 1.34, 1.27 and 
1.10 ppm 
[6, 9-2H2]-(+)-dethiobiotin methyl ester 61a 
This compound was prepared using a similar procedure to that described 
above using [2H]-Raney nickel at pH7, 
m/z (FAB , thioglycerol) 231.1677 [(M+1), C11H19N2032H2 requires 
231.1677]) 
4-Methyl-4-imidazolin-2-one 39 
To a solution of urea 36 (48g) in acetic acid (70m1) at 80°C was added 
acetol 37 (20.8g) and solid phosphomolybdic acid (10mg). The resulting 
reaction mixture was heated at reflux for 1.5 hour, then evaporated in 
vacuo until the weight was 95g, the residue taken up in water (95m1) and 
the pH adjusted to 8 with solid sodium carbonate. The basic solution 
was extracted with n-butanol (3 x 200ml) and the combined butanol 
extracts washed with sat.aq.NaCl solution (lxSOml). The organic extract 
was evaporated to 300ml and placed on ice overnight whereupon a 
colourless solid separated and was removed by filtration. The filtrate was 
evaporated to dryness, the residue taken up in hot water (lOmi) and 
cooled to 0°C which resulted in crystallisation of the imidazolinone 39 
(5.5g, 20%), m.p 204-208°C (lit.131, 202-2040C); 6H  ([2H6]DMSO, 60MHz) 
9.48 (2 H, hr d), 1.83 (3 H, s), 5.90 (1 H, s) ppm 
Ethyl 5-chioroformylpentanoate 67 
Adipic acid monoethyl ester (12.34g, 0.071mol) was heated at reflux in 
thionyl chloride (35ml) for 30 minutes. Excess thionyl chloride was 
removed by gentle heating (<40°C) of the mixture under reduced 
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pressure. The resulting product was purified by distillation under 
vacuum (0.3mm Hg) to afford ethyl 5-chioroformylpentanoate 67 as a 
clear yellow liquid (15.2g, 90%); b.p. 58°C (0.3mm Hg), 8H  (CDC13, 60 
MHz) 4.20 (2 H, q, J 7.1), 2.98 (2 H, m), 2.38 (2 H, m), 1.75 (4 H, m), 1.30 
(3 H, t, J 7.2) ppm; Om (film)/cm-1  1797 and 1728. 
6-Keto-7, 8-dehydrodethiobjotin ethyl ester 62 
To a stirred solution of 4-methyl-4-imidazolin-2-one 39 (5g, 0.052mo1) in 
dry CHC13 (30m1) and sulfolane (15ml) anhydrous aluminium trichloride 
(21g, 3xeq.) was added in aliquots held at ice temperature and under N2. 
Ethyl 5-chloroformylpentanoate 67 (11.5g, 0.06mol, 1.15xeq.) was then 
added slowly. The reaction mixture was heated at 65°C under N2 for 5 
hours (until HC1 evolution had ceased). Tlc analysis (silica, 20% 
methanol/ethyl acetate) indicated the reaction had gone to completion. 
The reaction mixture was cooled to room temperature and poured onto a 
ice/water mixture (100m!) containing sodium carbonate (8g). Ether 
(lOOml) was then added, the reaction mixture stirred at ice temperature 
for 30 mins and the resulting tan coloured precipitate isolated by 
filtration. The crude product was recrystallised from ethanol/water (1:1) 
to yield 6-keto-7,8-dehydrodethiobiotin ethyl ester 62 (5.4g, 42%) as 
yellow needles, m.p 171-173°C (lit.', 174-176°C); dH ([2H6]DMSO, 
360MHz) 10.73 (1 H, br s), 10.18 (1 H, hr s), 4.03 (2 H, q, J 7.1), 2.56 (2 H, 
t, J6.7), 2.29(211, t, J7.0), 2.25(3 H, s), 1.52(411, m), 1.16(3 H, t, J7.1) 
ppm; vmax(Nujo1)/cm 1  1733, 1697, 1640 and 1605. 
6-Dithioketal- 7, 8-dehydrodethiobiotin ethyl ester 71 
A solution of 6-keto-7,8-dehydrodethiobiotin ethyl ester 62 (0.4g, 
1.6mmol) in CHC13 (5ml) and 1,2-ethanedithiol (0.14m1, leq) was stirred 
under N2  and boron trifluoride etherate (0.4m1, 2eq) added. After stirring 
for 3 hours the mixture was washed with water (2x5ml), 1M KOH 
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solution (3x5ml) and again with water (2x5m1). The solvents were 
removed in vacuo to yield 6-dithioketal-7, 8-dehydrodethiobiotin ethyl 
ester 71 (0.44g, 85%) as a yellow gum; 5H  (CDC13, 200MHz) 10.72 (1H, br 
s), 9.70(1 H, br s), 4.02 (2 H, q, J7.1), 3.30 (4 H, m), 2.26 (4 H, m), 2.08 (3 
H, s), 1.52 (2 H, m), 1.29 (2 H, m), 1.15 (3 H, t, J 7.0) ppm; öc 11.09, 
13.91, 24.46, 27.02, 33.72, 39.02, 39.97, 42.81, 59.89, 66.39, 114.69, 
153.51, 173.01 ppm; m/z (FAB, thioglycerol) 331.1149 [(M+1), requires 
C14H23N203S2 331.1149] 
6-Keto-N,N'-diacetyl- 7,8-dehydrodethiobiotin ethyl ester 72 
6-Keto-7, 8-dehydrodethiobiotin ethyl ester 62 (0.70g, 2. 7mmol) was 
heated at reflux in acetic anhydride for 3 hours. The solvent was 
removed in vacuo to afford 6-keto-N,N'-diacetyldehydrodethiobiotin ethyl 
ester (0.80g) as a light brown residue, which dissolved ether (lOmi) and 
the solvent evaporated in vacuo to yield the crude diacetyl derivative as a 
solid. Recrystaffisation from ethanol/water (2:1) afforded 6-keto-7,8-
dehydrodethiobiotin ethyl ester 72 (0.76g, 82%) as white needles, m.p 71-
73°C (lit."°, 71-71.5°C); 8H  (CDC13, 200MHz) 4.11 (2 H, q, J 7.1), 2.61 
(3H,$), 2.58 (s, 3H), 2.35 (4 H,m), 2.09 (3 H, s), 1.76 (4 H, m), 1.23 (3 H, t, 
J7.1) ppm; vmax/cm' 1750, 1725, 1685 
6-Keto-N, N'-diacetyl-(±)-dethiobiotin ethyl ester 73 
6-Keto-N, N'-diacetyl-7, 8-dehydrodethiobiotin ethyl ester 72 (100mg, 
0.3mmol) in 1,4-dioxan (5m1) was hydrogenated at room temperature and 
pressure over 10% Palladium on charcoal (100mg). The theoretical 
uptake was 6.72cm3 of hydrogen for 1 mole equivalent, the actual uptake 
was 9cm3, completed after twelve hours. The catalyst was filtered off 
through celite and the filtrate evaporated in vacuo to leave a clear oil 
(92mg, 90%); a mixture of cis 73 and trans 74 isomeric products (82:18) by 
'H nmr analysis. 	The isomers were separated by dry flash 
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chromatography using ethyl acetate/chloroform (1:4) as the eluting 
solvent to yield the title compound 73 (76mg,75%) as a clear oil; 6H 
(CDC13, 360MHz) 4.78 (1 H, d, J 9.8), 4.55 (1 11, m), 4.04 (2 H, q, J 7.1), 
2.46 (311, s), 2.44 (3H, s), 2.50 (2 H, m), 2.25 (2 H, m), 1.59 (4 11, m), 1.17 
(3 H, t, J7.l), 1.12(311, d, J6.5) ppm. 
6-Hydroxy-N-acetyl-(±)-dethiobiotin ethyl ester 75 
6-Keto-N, N-diacetyl- (±)-dethiobiotin ethyl ester 73 (314mg, 0. 92mmol) in 
ethanol (8m1) was cooled in an ice bath to 0°C. To the stirring solution 
was added sodium borohydride (38mg, immol) in small aliquots. The 
reaction mixture was allowed to return to room temperature and left to 
stir for 1.5 hours. Acetic acid was added dropwise to destroy any excess 
sodium borohydride and the reaction mixture was poured onto ice/water 
(20ml). The aqueous mixture was then extracted with ethyl acetate 
(4x25ml), then washed with water (20m1). The organic extracts were 
dried (Na2SO4) and the solvent removed in vacuo to afford a clear oil. 
Crystallisation from ethanol gave 6-hydroxy-N-acetyl-(±)-dethiobiotin 
ethyl ester 75 (179mg, 65%) as a white microcrystalline solid, m.p. 128-
130°C (lit."° 129-1300C); 6H (CDC13, 200MHz) 6.74 (111, hr s), 4.55 (111, 
m), 4.12 (2H, q, J 7.0), 3.63 (111, hr s), 3.54 (1H, m), 2.91 (111, hr m), 2.40 
(311, s), 2.28 (2H, t, J 7.1), 1.60-1.27(611, m), 1.26 (3H, d, J6.5), 1.19 (3H, 
t, J 7.0) ppm; vmax/cm' 3460, 3240, 1735, 1685, 1665 
6-Keto-trans-(±)-dethiobiotin ethyl ester 76 
To a stirring solution of 6-keto-N,N'-diacetyl-(±).dethiobiotin ethyl ester 
73 (1.00g, 2.94mmol) in dry ethanol (5m1) under a N2 atmosphere was 
added freshly prepared sodium ethoxide (240mg, 3.5mmol) and the 
reaction mixture left to stir for one hour. AGW 50 (H) cation exchange 
resin was added to the reaction mixture and left to stir for thirty minutes. 
The resin was filtered off and the solvent evaporated in vacuo to give a 
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yellow oil. Dry flash chromatography (6% methanolidichloromethane) 
gave the title compound 76 as a clear oil (320mg, 43%); 8H (CDC13, 
200MHz) 6.50 (111, hr s), 6.00 (1H, br s), 4.03 (2H, q, J 7.1), 3.91 (111, d, J 
4.8), 3.65 (1H,m), 2.53 (2H, m), 2.25 (2H, m), 1.55 (411, m), 1.29 (3H, d, J 
6.3), 1.18 (311, t) ppm; 8c (CDC13, 50mhz) 202.3 173.20, 162.85, 67.42, 
60.11, 51.01, 37.70, 33.76, 24.06, 22.19, 13.99 ppm 
[6, 6-2H2]-trans-(±)-dethiobiotin ethyl ester 78 
6-Keto-trans-(±)-dethiobiotin ethyl ester 76 (50mg, 0.20mmol) in CH202 
(2m1) and 1,2-ethanedithiol (33L, 2eq) were stirred under N2 and boron 
trifluoride etherate (25.tL, leg) added. The reaction mixture was stirred 
rapidly for two hours and tic (silica, 15% methanol/dichioromethane) 
indicated the reaction had gone to completion. The mixture was diluted 
with CH2C12 (lOmi) and washed with saturated NaHCO3 solution 
(2x5ml), 15% NaOH solution (2x5ml) and brine (2x5ml). The organic 
extract was dried (Na2SO4) and the solvent removed in vacuo to give 6-
thioketal-trans-(+-)-dethiobiotin ethyl ester 77 (55.3mg, 83%) as a white 
solid. This was not isolated but dissolved in d4-methanol (2mi) and [21-1]-
Raney Nickel (0.5g, lml W-2 suspension, 50% slurry in D20) was added. 
The reaction mixture was heated under reflux for 4 hours and tic (silica, 
15% methanol/dichioromethane) indicated the reaction had gone to 
completion. The catalyst was filtered off through a celite plug and the 
solvent evaporated in vacuo to leave [6,6-2H2] -trans- (±) -dethiobiotin ethyl 
ester 78 as a clear oil (34mg, 84%), 811 (CDC13, 200MHz) 5.21 (111, hr s), 
5.04 (111, hr s), 4.08 (2H, q, J 6.9), 3.42 (111, m), 3.19 (1H, d, J 6.1), 2.27 
(2H, m), 1.64-1.54 (2H, m), 1.31 (411, m), 1.23 (3H, t, J 7.0), 1.19 (3H, d, J 
6.0) ppm; 6c (CDC13, 50MHz) 173.54, 162.80, 60.13, 54.06, 51.01, 34.01, 
28.73, 24.99, 24.55, 21.05, 14.10 ppm; m/z (FAB, thioglycerol) 245.1838 
[(M+1), C12H21N2032H2 requires 245.1834] 
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7, 8-Dehydrodethiobiotin ethyl ester 68 
A solution of 6-keto-7,8-dehydrodethiobiotin ethyl ester 62 (1.50g, 
5.9mmol) in glacial acetic acid (15m1) was added to pre-reduced Adams 
catalyst (Pt02) (500mgs) in glacial acetic acid (5m1) and the reaction 
mixture was stirred under an atmospheric pressure of deuterium for 6h. 
Calculated uptake for 2 moles = 264 cm3; uptake after 6 hours = 270cm3. 
The catalyst was filtered off through a celite plug and the solvent 
evaporated in vacuo to afford a light yellow oil. The residue was treated 
with ethanol and , on cooling (ice), a white precipitate appeared. This 
was filtered off to give 7,8-dehydrodethiobiotin ethyl ester 68 as 
colourless needles (0.80g, 56%), m.p. 190-192°C (lit.18  194-196°C); 611 
(CDC13, 200MHz) 10.15 (111, hr s), 10.01 (111, hr s), 4.18 (2H, q, J 7.1), 
2.38 (2H, t, J 7.3), 2.25 (2H, m), 2.02 (3H, s), 1.76-1.58 (611, m), 1.46-1.38 
(2H, m), 1.28 (311, t, J 7.1) ppm; 5c 173.53, 154.28, 116.92, 112.59, 59.45, 
33.11, 27.70, 27.43, 23.80, 22.45, 12.62, 7.03 ppm; m/z (FAB, 
thioglycerol) 241.1663, (M+1), C12H21N203 requires 241.1662 
Polydeuterated- 7,8-dehydrodethiobiotin ethyl ester 70 
A stirring solution of Adams catalyst (Pt02) (250mg) in di-acetic acid 
(3m1) was pre-reduced under an atmosphere of D2 for 30 minutes. 6-Keto-
7,8-dehydrodethiobiotin ethyl ester 62 (0.55g, 2.18mmol) in AcOD (lmi) 
was added and the reaction mixture was stirred under an atmospheric 
pressure of D2 until tic (silica, CHC13/MeOH/AcOH, 90:5:5) indicated the 
reaction had gone to completion (calculated for moles of deuterium: 
108cm3; Found : 123cm3) The catalyst was filtered off through a celite 
plug and the solvent evaporated in vacuo to give a white solid. 
Recrystallisation from ethanol gave the title compound 70 as white 
needles. m.p. 186-187°C; 811 (CDC13, 250MHz) 10.15 (111, br s), 10.00 (1H, 
br s), 4.05 (2H, q, J 7.1), 2.23 (2H, t, J 7.5), 1.50-1.32 (3H, m), 1.23 (2H, 
m), 1.16 (3H, t, J 7.1) ppm; 5c (CDC13, 50MHz) 173.62, 155.46, 117.07, 
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112.71, 60.05, 34.02, 27.96, 27.85, 24.32, 14.02; 8D (1120, 55MHz) 2.39, 
2.22, 1.99, 1.55, 1.33 ppm; m/z (FAB, thioglycerol) 242 (+2H, 2.9%), 243 
(+2112, 13.5%), 244 (+2H3, 13.5%), 245 (+2H4, 30.9%), 246 (+2H5, 58.5%), 
247 (+2H6, 77.8%), 248 (+2117, 83.7%), 249 (+2H8, 77.4%), 250 (+2119, 
51.4%), 251 (+2Hio, 23.7%) 
Imidazolin-2-one 42 
A ground mixture of (±)-tartaric acid 41 (21g, 0.14mol) and urea 36 (7.5g, 
0.125mo1) was slowly added to a stirring solution of fuming sulphuric acid 
(50m1) such that the temperature did not exceed 650C without external 
cooling. The resultant mixture was heated at 800C for 1 hour until the 
evolution of gas had ceased, cooled to 200C and poured onto crushed ice 
(500g). The resulting brown coloured precipitate was then washed with 
water (250m1) and acetone (50m1) to afford 4-carboxyimidazolin-2-one 
(9.5g, 53%), m.p. 226-2300C (lit.132 232-2350C). A solution of this 
compound (9g, 0.07mol) in aq.K2CO3 (0.25M, lOOmi) was heated at reflux 
for 4 hours, charcoal (ig) added, and the solution heated at reflux for a 
further 0.5 hours. The solution was hot filtered and the solvent 
evaporated under reduced pressure to Ca. 50m1 and the resulting 
precipitate washed with acetone (20ml) and ether (20m1) to give 
imidazolin-2-one 42 (4.7g, 75%), m.p. 238-2400C (lit.132  240-2410C); 8H 
([2116]..DMSO, 60MHz) 9.70 (2H, hr d), 6.23 (211, hr s) ppm 
4-Ethyl-4-imidazolin-2-one 40 
A mixture of urea 36 (48g, 0.8mol) and glacial acetic acid (70ml) was 
heated until a clear solution was obtained whereupon 1-hydroxy-2-
butanone 38 (24.7g, 0.28mo1) and solid phosphomolybdic acid (10mg) was 
added. The reaction mixture was heated under reflux for 3 hours. The 
acetic acid was removed in vacuo then 1,4-dioxan (lOOmi) added and 
evaporated to remove any residual acetic acid azeotropically. The brown 
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coloured residue was dissolved in water (150m1) and solid sodium 
carbonate was added until the pH of the solution was Ca. 9. The resulting 
mixture was extracted with CH202 (2x400m1) and then n-butanol 
(3x300m1). The combined n-butanol extracts were evaporated in vacuo, 
the resulting orange oil taken up in water (25ml) and cooling at ice 
temperature resulted in the formation of a yellow solid . The solid was 
collected by filtration and recrystaffisation from water gave 4-ethyl-4-
imidazolin-2-one 40 as a yellow microcrystalline solid (8g, 25%),m.p .174-
1750C (lit.1 ,179-1800C); 6H ([2H6]-DMSO, 200MHz) 10.03 (1H, br s), 9.65 
(1H, br s), 5.92 (1H, s), 2.20 (2H, q, J 7.5), 1.03 (3H, t, J 7.5) ppm; 5c 
([2H6]..DMSO, 50MHz) 172.30, 124.11, 103.30, 18.69, 12.62 ppm; m/z 
(FAB, thioglycerol) 113.0713 (M+1), C5H9N20 requires 113.0714 
Friedel-Crafts acylation of imidazolin-2-ones 
A slurry of imidazolinone (30mmol) in sulfolane (12.4m1) and dry 
chloroform (30m1) was cooled to ice bath temperature and anhydrous 
aluminium trichloride (20.1g, 150mmol, 5eq) was added portionwise. 
After the addition was complete, the temperature was raised to 650C and 
the acid chloride monoethyl ester (45mmol, 1.5eq) was added dropwise 
over a period of an hour. On heating an additional 3 hours, tic (silica, 
20% methanol/ethyl acetate, phosphomolybdic acid visualisation) showed 
the reaction had gone to completion. The reaction mixture was poured 
onto ice (200g) containing Na2CO3  (4.4g) in water (25m1). The hydrolysis 
mixture was stirred rapidly and diethyl ether (150ml) was added. The 
resulting precipitate was isolated by filtration and dried under vacuum to 
give the crude product. Recrystallisation from ethanol/water (1:1) gave 
the corresponding substituted imidazolin-2-ones 
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4-(5-Ethoxycarbonylpentanoyl)-imidazolin-2-one 43 
(2.35g, 35%), m.p.2420C (lit.186 239-2420C); (Found: C,55.2; 11,6.65; 
N,11.4. C11H16N204 requires C, 55.0; H, 6.7; N, 11.65%); 6H ([2116]-DMSO, 
200MHz) 10.77 (111, br s), 10.48 (1H, br s), 7.62 (1H, s), 4.00 (211, q, J 
7.1), 2.56 (2H, t, J7.0), 2.28 (2H, t, J7.0), 1.52 (4H, m), 1.15 (3H, t, J7.1) 
ppm; öc ([2116]-DMSO) 187.35, 172.16, 153.50, 122.82, 120.32, 59.07, 
32.97, 32.64, 23.60, 23.46, 13.47 ppm 
4-Ethyl-(5-ethoxycarbonylpentanoyl)-imidazolin-2-one 44 
(2.41g, 30%), m.p. 104-1050C (1it.18  108-1090C); (Found : C, 58.45; H, 
7.45; N, 10.25. C13H20N204 requires C, 58.2; H, 7.5; N, 10.45%); oH ([2116].. 
DMSO, 200MHz)) 10.81 (111, br s), 10.24 (111, br s), 4.01 (211, q, J 7.1), 
2.65 (2H, q, J 7.5), 2.56 (211, m), 2.28 (2H, m), 1.51 (411, m), 1.15 (311, t, J 
7.1), 1.10 (3H, t, J 7.5) ppm; Oc ([2H6]-DMSO, 50MHz) 188.90, 172.92, 
152.89, 135.44, 118.03, 59.82, 38.65, 33.48, 24.21, 23.19, 18.79, 14.24, 
13.09 ppm 
4-Methyl- 5-(3-ethoxycarbonylpropanoyl)-imidazolin-2-one 45 
(2.64g, 39%), m.p. 227-2280C ; (Found : C, 53.05; H, 6.3; N, 12.3. 
C10H14N204 requires C, 53.1; H, 6.25; N, 12.4%); OH ([2H6]-DMSO, 
200MHz) 10.78 (1H, br s), 10.26 (1H, hr s), 4.01 (2H, q, J 7.1), 2.84 (211, t, 
J 5.8), 2.52 (211, t, J 5.8), 2.27 (311, s), 1.16 (311, t, J 7.1) ppm; Oc ([2H6] 
DMSO, 50MHz) 186.76, 172.50, 152.71, 130.28, 118.91, 59.97, 34.01, 
27.55, 14.20, 11.88 ppm 
4-Methyl- 5-(4-ethoxycarbonylbutanoyl)-imidazolin-2-one 46 
(3.02g, 42%), m.p. 1860C; (Found : C, 54.65; H, 6.5; N, 12.0. C11H16N204 
requires C, 55.0; H, 6.7; N, 11.65%); 811 ([2H6]..IDMSO, 80MHz) 10.72 (1H, 
hr s), 10.13 (111, hr s), 4.00 (211, q, J 7.1), 2.59 (2H, t, J 6.1), 2.30 (211, t, J 
6.2), 2.25 (3H, s), 1.76 (2H, m), 1.16 (3H, t, J 7.1) ppm; Oc ([2116]-DMSO, 
113 
50MHz) 188.19, 172.86, 152.72, 130.18, 119.18, 59.95, 38.05, 32.97, 19.22, 
14.26, 11.89 ppm 
4-Methyl-5-(6-ethoxycarbonylhexanoyl)-imidazolin-2-one 47 
(3.21g, 40%), m.p. 152-154°C; (Found : C, 58.0; H,7.8; N, 10.15. 
C13H20N204 requires C, 58.2; H, 7.5; N, 10.45%); 8H ([2H6]-DMSO, 
250MHz) 10.74 (1H, br s), 10.19 (1H, brs), 4.01 (2H, q, J 7.1), 2.54 (211, t, 
J 7.2), 2.25 (3H, s), 2.22 (2H, t, J 6.75), 1.51 (4H, m), 1.26 (2H, m), 1.15 
(3H, t, J 7.1) ppm; 8c ([2H6]-DMSO, 50mhz) 188.73, 172.98, 152.68, 
129.80, 119.12, 59.79, 39.26, 33.55, 28.26, 24.47, 23.42, 14.22, 11.81 ppm 
4-Methyl- 5-(7-ethoxycarbonylheptanoyl)-imidazolin-2 -one 48 
(2.79g, 33%), m.p. 1540C; (Found: C, 59.4; H, 7.55; N, 10.0. C14H22N204 
requires C, 59.55; H, 7.85; N, 9.95%); oH ([2H6]-DMSO, 250 MHz) 10.74 
(1H, hr s), 10.19 (111, br s), 4.01 (211, q, J 7.1), 2.53 (211, t, J 7.2), 2.25 
(3H, s), 2.21 (2H, t, J 7.2), 1.49 (4H, m), 1.25 (411, m), 1.15 (3H, t, J 7.1) 
ppm; Oc ([2H6]-DMSO, 50MHz) 188.80, 172.99, 152.67, 129.74, 119.13, 
59.76, 39.60, 33.57, 28.42, 24.46, 23.57, 14.22, 11.81 ppm 
Catalytic hydrogenation of substituted imidazolinones 
The substituted imidazolinone (1.5mmol) was dissolved in glacial acetic 
acid (2m1) and added to a stirring solution of pre-reduced Adams catalyst 
(Pt02, 150mg) in glacial acetic acid (2ml). The reaction mixture was 
hydrogenated at room temperature and atmospheric pressure until the 
uptake of hydrogen had ceased. The catalyst was filtered off through a 
celite plug and the solvent evaporated in vacuo to afford the 
corresponding modified dethiobiotin ethyl esters as clear oils which were 
of sufficient purity for the next step: 
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4-(5-Ethoxycarbonylpentyl)-imidazolidin2one 49 
From 43 (291mg, 85%); 8H (CDC13, 250MHz) 6.24 (1H, hr s), 5.88 (111, hr 
s), 4.06 (2H, q, J 7.1), 3.72 (1H, m), 3.53 (111, m), 3.06 (1H, m), 2.23 (211, 
t, J 7.5), 1.60-1.47 (411, m), 1.31-1.25 (411, m), 1.18 (3H, t, J 7.1) ppm; 8c 
(CDC13, 50MHz) 173.51, 165.11, 60.04, 52.86, 46.45, 35.36, 33.92, 28.65, 
24.88, 24.46, 14.00 ppm; m/z (FAB, thioglycerol) 229.1551. (M+1), 
C11H21N203 requires 229.1552 
4-Ethyl-5-(5-ethoxycarbonylpentyl)-jmjdazoljdjn-2-one 50 
From 44 (250mg, 65%); H(CDC13, 250MHz) 7.89 (1H, hr s), 6.18 (111, hr 
s), 4.08 (2H, q, J 7.1), 3.69-3.58 (2H, m), 2.29 (2H, t, J 7.2), 1.67-1.24 
(1011, m), 1.21 (3H, t, J 7.1), 0.91 (311, t, J 7.2) ppm; 6c(CDC13, 50MHz) 
173.55, 164.85, 60.08, 57.72, 56.05, 34.00, 29.20, 28.83, 25.87, 24.51, 
22.44, 14.04, 10.55 ppm; m/z (FAB, thioglycerol) 257.1865. (M+1), 
C13H25N203 requires 257.1865. 
4-Methyl- 5-(3-ethoxycarbonylpropyl)-imidazolidin-2-one 51 
From 45 (289mg, 90%); 8H (CDC13, 250MHz) 6.22 (111, hr s), 5.86 (111, br 
s), 4.07 (211, q, J 7.1), 3.78 (1H, m), 3.69 (111, m), 2.30 (2H, t, J 7.2), 1.49 
(411, m), 1.20 (3H, t, J 7.1), 1.07 (3H, d, J 6.3) ppm; 8c (CDC13, 50MHz) 
173.07, 164.57, 60:26,  55.70, 51.25, 33.72, 28.97, 21.51, 15.28, 13.97 ppm; 
m/z (FAB, thioglycerol) 215.1403. (M+1), C10H18N203 requires 215.1395 
4-Methyl- 5-(4-ethoxycarbonylbutyl)-imidazolidin-2-one 52 
From 46 (263mg, 77%); 6i-i (CDC13, 250MHz) 6.35 (111, hr s), 6.01 (111, hr 
s), 4.03 (211, q, J 7.1), 3.75 (1H, m), 3.63 (1H, m), 2.25 (211, t, J 7.6), 1.55 
(2H, m), 1.39-1.24 (4H, m), 1.17 (311, t, J 7.1), 1.03 (3H, d, J 6.4) ppm; öc 
(CDC13, 50MHz) 173.32, 164.70, 60.03, 55.76, 51.18, 33.71, 29.10, 25.67, 
24.52, 15.24, 13.94 ppm; m/z (FAB, thioglycerol) 229.1549. (M+1), 
C11H20N203 requires 229.1552 
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4-Methyl-5-(6-ethoxycarbonylhexyl)-im idazolidin-2-one 53 
From 47 (338mg, 88%); 6H (CDC13, 250MHz) 6.06 (111, br s), 5.76 (1H, hr 
s), 4.04 (2H, q, J 7.1), 3.79 (111, m), 3.63 (1H, m), 2.22 (2H, t, J 7.3), 1.77-
1.21 (1011, m), 1.19 (311, t, J 7.1), 1.06 (311, d, J 6.3) ppm; 8c (CDC13, 
50MHz) 173.61, 164.58, 60.00, 56.01, 51.27, 34.02, 29.34, 28.98, 28.65, 
26.03, 24.59, 15.32 ppm; 14.00; m/z (FAB, thioglycerol) 257.1865. (M+1), 
C13H25N203 requires 256.1865 
4-Methyl- 5-(7-et hoxycarbonylheptyl)-im idazolidin-2-one 54 
From 48 (316mg, 78%); 8H (CDC13, 250MHz) 6.12 (111, hr s), 5.89 (111, br 
s), 4.06 (211, q, J 7.1), 3.76 (111, m), 3.63 (111, m), 2.21 (2H, t, J 7.2), 1.56-
1.24 (12H, m), 1.17 (311, t, J 7.1), 1.03 (3H, d, J 6.4) ppm; 8c (CDC13, 
50MHz) 173.59, 164.65, 59.91, 55.96, 51.20, 34.01, 29.32, 29.09, 28.72, 
26.09, 24.58, 15.24, 13.94 ppm; m/z (FAB, thioglycerol) 271.2022. (M+1), 
C14H27N203 requires 271.2021. 
Preparation of aberrant DAPA analogues 
Substituted imidazolidin-2-one (0.7mmol) and barium hydroxide 
octahydrate (500mg) in water (2m1) were heated in a sealed vial at 1300C 
for 3 days. After cooling, the reaction mixture was filtered to remove any 
excess barium hydroxide and the filtrate and washings (total volume 5m1) 
were acidified to p111.5 with concentrated sulphuric acid. The resulting 
barium sulphate precipitate was removed by centrifugation, the 
supernatants combined and the solvent evaporated in vacuo to Ca. 1 ml. 
On addition of methanol (3m!), a white solid precipitated out which was 
collected by filtration. Recrystallisation from water/methanol afforded 
the corresponding DAPA analogues isolated as their sulphate salts: 
are 
7,8-(±)-Diaminooctanojc acid sulphate 30 
From 49 (104mg, 55%), m.p. 238-239°C; (Found:C, 35.25; H, 7.1; N, 10.0. 
C8H20N206S requires C, 35.3; H, 7.35; H, 10.0%); SH (D20, 250MHz) 
3.70(1H, m), 3.51 (1H, m), 3.02 (1H, m), 2.25 (2H, t, J 7.3), 1.62-1.43 (4H, 
m), 1.32-1.25 (4H, m) ppm; Sc (D20, 50MHz) 178.15, 51.12, 46.23, 34.17, 
29.1, 26.1, 25.92, 24.91 ppm 
7,8-(±)-Diaminodecanojc acid sulphate 31 
From 50 (74mg, 35%), m.p 249-250°C; (Found:C, 39.7; H, 8.35; N, 9.1. 
C10H24N206S requires C, 40.0; H, 8.05; N, 9.3%); SH (D20, 250MHz) 3.64-
3.51 (2H, m), 2.38 (2H, t, J 7.3), 1.87-1.38 (10H, m), 1.05 (3H, t, J 7.4) 
ppm; Sc (D20, 50MHz) 179.03, 54.20,52.49, 33.64, 27.82, 27.65, 24.32, 
23.85, 21.42, 9.22 ppm 
6-(±)-Diaminoheptanoic acid sulphate 32 
From 51 (71mg, 45%), m.p. 236-238°C; (Found:C, 32.2; H, 6.9; N, 10.9. 
C7H18N204S requires C, 32.5; H, 7.0; N, 10.85%); SH (D20, 250MHz) 3.88-
3.73 (2H, m), 2.36 (2H, t, J 7.3), 1.77-1.48 (4H, m), 1.03 (3H, d, J 6.4) 
ppm; Sc (D20, 50MHz) 178.29, 55.73, 51.51, 33.55, 28.32, 21.18, 14.33 
PPM 
7-(±)-Diaminooctanoic acid sulphate 33 
From 52 (108mg, 57%), m.p. 244-245°C; (Found: C, 35.1; H, 7.5; N, 10.25. 
C8H20N206S requires C, 35.3; H, 7.4; N, 10.3%); SB (D20, 250MHz) 3.72 
(1H, m), 3.57 (1H, m), 2.39 (2H, t, J 7.3), 1.78-1.56 (6H, m), 1.48-1.41 (2H, 
m), 1.36 (3H, d, J 7.0) ppm; Sc (D20, 50MHz) 178.61, 52.28, 48.20, 33.29, 
28.56, 23.92, 23.66, 12.85 ppm 
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8,9-(±)-Diaminodecanoic acid sulphate 34 
From 53 (100mg, 48%), m.p. 257-258°C; (Found:C, 40.0; H, 8.35; N, 9.1. 
C10H24N206S requires C, 40.0; H, 8.05; N, 9.3%); 6H (D20, 250MHz) 3.74 
(1H, m), 3.61 (1H, m), 2.43 (2H, t, J 7.3), 1.81-1.59 (4H, m), 1.45 (3H, d, J 
7.0), 1.39 (6H, m) ppm; 8c (D20, 50MHz) 177.79, 53.57, 48.38, 33.76, 
33.64, 28.85, 27.84, 24.31, 24.12, 13.01 ppm 
9, 1O-(±)-Diaminoundecanoic acid sulphate 35 
From 54 (115mg, 52%), m.p. 2740C; (Found:C, 42.3; H, 8.7; N, 8.9. 
C11H26N206S requires C, 42.0; H, 8.35; N, 8.9%); 5H (D20, 250MHz) 3.75 
(1H, m), 3.58 (1H, m), 2.30 (2H, t, J 7.3), 1.78-1.55 (4H, m), 1.41 (3H, d, J 
7.0), 1.34 (8H, m) ppm; öc (D20, 50MHz) 181.36, 53.55, 48.34, 35.41, 
28.15, 28.05, 27.99, 27.91, 24.84, 24.35, 13.02 ppm 
Purification of E.coli Dethiobiotin Synthetase 
The bioD gene from Xbio256 DNA was cloned into a modified pUC8 vector 
into which a 91bp tac promoter block has previously been inserted. The 
recombinant plasmid, pBD8, was used to transform E.coli JM83130.  E.coli 
JM83/pBD8 was grown in LB medium (500m1) containing 50jig/ml 
ampicilhin for 12h at 370C in shake flasks (250rpm). Aliquots of the 
culture (50m1) were diluted to 500m1 with fresh ampicillin containing 
medium and shaken for 6h at 370C. The cells were harvested by 
centrifugation (5000g, 10mm, 40C) and the cell pellet resuspended in 
50mM Tris buffer (pH 7.5) containing MgSO4 (5mM) and DTT 
(300mM)[Buffer A] (typically 5mIIL of culture suspension). 	The 
concentrated cell suspension was sonicated for Amin on ice (14 bursts of 
30s with 30s cooling periods) and centrifuged (15,000g, 20mm, 40C). The 
cell debris were resuspended in lOmi Buffer A and the sonication and 
centrifugation procedure repeated. The supernatants were combined and 
2% protamine sulphate in Buffer A was slowly added. The solution was 
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stored at 40C overnight and then centrifuged (15,000g, 20mm, 40C). The 
supernatant was adjusted to 45% in (NH4)2SO4 by slow addition of 
(NH4)2SO4, stirred for 5h at 40C and centrifuged (15,000g, 30mm, 40C). 
The protein pellet was solubilised in Buffer A and loaded on a Sephacryl 
S-200 (3 x 40cm) equilibriated with Buffer A and the proteins eluted at a 
flow rate of imi/min. Fractions containing DTB synthetase were pooled 
and applied to a Sepharose Q fast flow anion exchange column (2 x 30cm) 
equilibriated with 50mM bis-tris-propane-HC1 (pH7.2) containing MgSO4 
(5mM) and DTT (300mM) 
[buffer B]. The column was washed with Buffer B (30m1) and the 
proteins eluted with a linear salt gradient (0-250mM NaCl in Buffer B). 
Active fractions were combined and dialysed against 50% (NH4) 4 
dissolved in Buffer A (final pH 7.2) for 15h. The precipitate was removed 
by centrifugation (10,00g, 20 mm, 40C) and resuspended in Buffer A 
(5m1). Desalting was effected by FPLC on a Pharmacia desalting column 
(1 x 10cm) using Buffer A as eluant affording homogeneous protein 
(1.2mg/mi; typically 3 mg/L of the original culture). 
Determination of Dethiobiotin Synthetase Activity 
The assay was based on the procedure described by Rosing et al.188. 
Solutions were prepared immediately prior to the assay and stored on ice 
during mixing: 
Solution A- Tricyciohexylammonjum phosphoenoi pyruvate (10mg/mi, 
20mM), disodium ATP (10mg/mi, 17mM), MgSO4 (0.33mM) and KC1 
(1.33mM); Solution B- disodium NADH (10mg/mi, 14mM); Solution C-
pyruvate kinase (2U/jti) and L-lactate dehydrogenase (lU4tl) suspended 
in ammonium sulphate (3.2M, pH6.0); Solution D- DTT (3mM) in tris-
HC1 (50mM, pH 8.0) was kept at ambient temperature before mixing. A 
2.34 ml aliquot of a solution of NaHCO3 (0.1M) and DTT (3mM) in tris-
HC1 (50mM, pH 7.7) (having a final pH of 8.0 at 250C) was stirred in a 
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1cm pathlength plastic cuvette at 250C and aliquots of solution A (300.11), 
solution B (50d), solution C (10tl) and solution D (200p.l) added. After 2 
min the enzyme solution was added (50j.tl, 2tM) and after a further 10 
min 10-50.t1 of an aqueous solution of DAPA sulphate (1mg/mi) was 
added. The NADH absorbance at 340nm was monitored prior to addition 
of substrate and for a further 10 mm. The activity of DTB synthetase, 
corrected for non-specific ATP'ase activity, was calculated as (A340 min') 
x 0.482 units, where one unit is defined as the consumption of lp.mol.' 
NADH (or ATP) min'. 
Kinetic measurements 
UV measurements were carried out using a Hewlett Packard 8452A 
Diode Array Spectrophotometer with a SFA-20 Rapid Kinetics Stopped-
Flow Accessory (Hi-Tech Scientific Ltd., Salisbury, UK). Reaction 
temperatures were maintained at 250C (+10C) on 0.1 M tris buffer 
containing 50mM KC1, 0.2mM EDTA, 0.5mM 2-mercaptoethanol (and 
2mM MgC12) adjusted to pH7.8 at 250C with enzyme concentrations of 
0.5-1.0 M. Data were collected using a HP Vectra VL2 4/50 computer 
and analysed on line using various software products (HP 89532A 
General Scanning Software, HP 89532K UV-Visible Kinetics Software 
and SPECFIT v2.0, Spectrum Software Associates, Chapel Hill, NC, 
USA). The coefficients kob, kob8l and kobs2 were determined using non-
linear regression by a combination of the Levenberg-Marquardt 
algorithmn and the simplex method. Values of ki, k 1 and k2 were 
obtained from kobs/[substrate]  plots. k 2 was estimated by fitting the 
kinetic model to time dependent absorption changes in the 200-400 nm 
range using experimental values for k1, k 1 and k2 and initial conditions 
[PAPA analogue]4mM, [DTBS]=60.tM, [CO2]2mM  and [DTBS-Mg2 -
DAPA analogue] [DTBS-Mg2 -DAPA analogue. CO2] 0  
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Protein Assays 
Accurate protein concentrations for kinetic measurements were 
determined by UV spectrophotometry using corrections to allow for 
interfering substances' 9. 	For three independent experiments 
reproducibility was +- 2%. The Bradford method'90 (standardised against 
BSA) was used for routine protein concentration determinations. 
Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis (SDS-
PA GE) 
SDS-PAGE was carried out using the discontinuous buffer system of 
Laemmli'91. Molecular weight determinations were carried using SDS-
PAGE and phosphorylase b, bovine serum albumin, ovalbumin, carbonic 
anhydrase, soybean trypsin inhibitor and lysozyme as low molecular 
weight standards. Myosin, a2-macroglobulin, 3-galactosidase, transferrin 
and glutamic dehydrogenase were used as high molecular weight 
standards. 
Crystallisation of Dethiobiotin Synthetase 
Crystallisation of the protein was effected from 50mM cacodylate-HC1 
buffer (pH 6.0) by dialysis against a 0.5M (NH4)2SO4 solution in the same 
buffer as reported earlier72. 
The substrate soaking experiments were carried out as follows. The 
native enzyme crystals were grown in the absence of Mg2 and were of 
typical dimension 0.2mm x 0.2mm x 0.2mm. Crystals were added to a 
well solution containing MgSO4 (20mM) and (n-1)-(+-)-DAPA (100mM) 
and left to soak overnight. Details of the X-ray data sets collected from 








Mult. a 	b 	c 
(n-1)-DAPA 2.3 99.9 21.1 9.8 4.9 72.71 	49.48 	61.19 
(100.0) (5.8) (33.9) 
AA-(n-1)- 2.0 91.6 16.2 4.4 2.4 72.15 	48.62 	60.57 
DAPA-Mg2 (92.5) (7.0) (9.5) 
CO2-(n-1)- 1.9 99.5 17.0 5.7 3.1 71.78 	48.25 	60.62 
DAPA-Mg2 (97.1) (4.1) (21.5) 
Table 6.1 Crystallographic details of data collection and processing. Data was 
recorded for (n-1)-DAPA (in the absence of Mg2 ) at room temperature and 
under an ambient atmosphere (AA). The other two data sets were collected at a 
temperature of lOOK and under the atmosphere stated. 
40% glycerol was used as cryoprotectant for cryocooling experiments. For 
the carboxylation experiment the crystals were equilibriated in an 
atmosphere of CO2 for 3 hours before cryocooling. 
X-ray data for the substrate soaked crystals were collected on station 7.2 
at the SRS, Daresbury Laboratory at a wavelength of 1.488A using an 
18cm MAR image plate system. Data were processed with DENZO-
SCALEPACK19 . 
Preliminary binding studies at room temperature of crystals soaked in (n-
1)-(±)-DAPA (100mM) in the absence of Mg2 showed no substrate 
binding. These crystals of DTBS were isomorphous with the native 
crystals without the substrate and the difference Fourier map with 
coefficients (Fsoak-Fnat), Dnat was featureless indicating that no binding 
occurred without Mg2 . The cryocooled crystals of DTBS, previously 
soaked in the (n-1)-(±)-DAPA (100mM) and MgSO4 (20mM), were not 
isomorphous with the native crystals but to crystals containing the 
parent DAPA at lOOK, the structure of which was already determined to 
1.6A resolution. 
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The structure factors FDAPA, cDDAPA from the refined model of the native 
substrate bound to DTBS were used in the Fourier analysis. The Fourier 
maps with coefficients (3Fsoak-2FDApA), cIDAPA for the soaks in the presence 
of Mg2 showed the substrate clearly in the ambient atmosphere and 
under CO2. The density corresponding to the bound substrate was the 
major feature of both maps and the substrate could be localised 
unambiguously. The shortened substrate was easily recognised in the 
map that used phases from the bound native substrate. 
The starting model was built with the program '0'194  and refined with the 
program XPLORI95 independently for both cases. The difference Fourier 
analysis based on the phases from each model indicated that the bound 
structures are indistinguishable and no carboxylation was detected. The 
R-factor between the two models was 15.4%. 
BlO TIN SYNTHASE 
Bacterial Strains and Plasm ids 
E.coli DH1i (bio+, recA, hsclR, thil, placi) was used as a host strain. The 
bioABFCD mutant pCOi (bio-, iX(attk bio uvrB), thr, leu, thi, placi) lacks 
the biotin operon and therefore has an absolute requirement of biotin for 
growth. The E.coli bioB gene was cloned from Xbio256 DNA. The 
recombinant plasmid pIMSB was obtained from the insertion of bioB into 
a pKK223-3 (Pharmacia) derived vector which was under the control of 
the tac promoter. 
Preparation of cell-free extracts of DH1 i /pIMSB 
E.coli DH1iJpIMSB was grown in LB medium (lOml) supplemented with 
ampicillin (50p.g/ml) and tetracycline (12.5ig/m1) overnight at 370C and 
this was used to innoculate 500m1 of identical broth. The cells were 
grown in shake flasks (250rpm) at 370C until the 0D600 was 1.0 (ca.3h). 
Aliquots of this culture (50m1) were diluted to 500m1 with fresh 
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supplemented LB medium and shaken at 370C until 0D600 was 0.4 
(ca. 2h). The cells were then induced with IPTG at a final concentration of 
lOj.tM and grown for a further 3h (final 0D600 ca.1.8). The cells were 
collected by centrifugation (5,000rpm, 5mm, 40C) and the cell pellet 
resuspended in Tris buffer (50mM, pH 7.5) (ig wet weight cells/ml). The 
concentrated cell suspension was sonicated for 10 minutes on ice (10 
bursts of 30s with 30s cooling periods) and centrifuged (15,000rpm, 
15mm, 40C).  The supernatants were collected and stored as 5m1 aliquots 
at -20°C. 
pCOi cell-free extract was prepared in a similar manner. 
Partial Purification of bioB gene product 
DH1iJpIMSB cell-free extract (5m1, 34mgml-') was fractionated at ice 
temperature by the addition of solid ammonium sulphate to 20% 
saturation, left to stir for 2h at 40C and then centrifuged (15,000g, 30mm, 
40C). The supernatant was brought to final concentration of 50% with 
solid ammonium sulphate at ice temperature, left to stir for 2h at 40C and 
then centrifuged (15,000g, 30mm, 40C). the pellet was resuspended in 
Tris buffer (50mM, pH 7.5) (5ml) and dialysed against the same buffer 
overnight. The dialysed fraction (imi) was loaded onto Q-sepharose 
anion exchange column ( Socm A 3 c.rn 	equilibriated with Tris buffer 
(50mM, pH 7.5). The column was washed with Tris buffer (SOml) and the 
proteins eluted (1.2mlmin-1) witha linear salt gradient (0-1M NaCl in the 
same buffer). The bioB gene product eluted between 300mM and 400mM 
salt. 
11C CAP-SEP Biotin Assay 
A.Incubation 
A standard reaction mixture contained pbioB extract (100p.1), pCOi (bio-) 
(lOOp.l) and the necessary cofactors in a final volume of 500p.l. The 
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cofactors and their final concentrations are as follows: S-adenosyl-L-
methionine (0.1mM), KC1 (10mM), NADPH (1mM), Fe(NH4)2(SO4)2 
(5mM), L-Giutamic acid (20mM), Thiamine pyrophospate (0.5mM), L-
cysteine (5mM) and 20.ti 14C-DTB (0.2.tCiJ20tL) (0.75j.tg/0.2Ci). All 
cofactor solutions were made up in Tris buffer (50mM, pH 7.5). The 
reaction mixture was incubated at 370C for two hours. The reaction was 
stopped by the addition of trichloroacetic acid (200.ti, 10%w/v). DTB 
(20m1, 10mg/mi) and biotin (20m1, 10mg/mi) were added as carriers, the 
eppendorf tilted and the precipitated protein spun down in a 
microcentrifuge (15,000g, 30sec). 
B. Supernatant work-up 
A CAP-SEP C18 reverse phase column was washed with methanol (2mls) 
then distilled water (5mls). The supernatant from the reaction mixture 
was loaded onto the column and washed with acetic acid (2m1, 1%v/v) and 
distilled water (2m1). The radioactive dethiobiotin and biotin were then 
eluted with methanol (lml) into an eppendorf and the solvent blown off 
with nitrogen. The dry sample was resuspended MeOH/0.1M NaOH 
(lOOj.il, 1:1). An aliquot (10.t1) was applied to a tic plate (silica, 10 x 
10cm) and run using a chloroform: 15% methanol: 0.1%formic acid 
(17:3:0.2) solvent system. The tic plate was allowed to dry and was 
exposed overnight to a hyperfflm-l3max 	autoradiography film 
(Amersham). After exposure, the film was developed (5mm), fixed 
(10mm) and rinsed in cold water (5mm). Radioactive biotin (Rf 0.47 ) was 
identified from the developed film and the amount of biotin synthesised 
was calculated by scintillation counting of the radioactive zones cut from 
the tic plate. 
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Microbiological Biotin Assay 
The incubation procedure was as described above except (+)-DTB (50p.M) 
was used in place of 14C-DTB and the reaction was stopped by boiling for 
5mm. After centrifugation, the supernatant was assayed for biotin using 
the paper disc plate method with Lactobacillus plantarum138. Several 
standards of authentic biotin- were used on each assay plate (0. 1, 0.2, 0.5, 
1.0, 5.0, 10.0 pg/ml) and data obtained was the average of at least 
duplicate experiments. 
Cysteine Desulphurase Radiochemical Assay 
A typical incubation contained an aliquot of protein extract (50tl), 14C-L. 
cystine (Amersham, (10.1, 0.2j.Ci, 291.3mCi/mmol) and L-cysteine 
(200jiM) in Tris buffer (50mM, pH 7.5) containing DTT (2mM) . The 
reaction mixture was made up to a final volume of 70pi  and incubated at 
370C for 3h. The reaction was stopped by boiling for 5 min and the 
denatured protein centrifuged (15,000g, 30s). An aliquot (5tl) of the 
supernatant was removed for scintillation counting. The remaining 
supernatant (40.tl) was transferred to a fresh eppendorf and lOjtl L-
cysteine (1mg/mi) and lOjtl L-alanine (1mg/mi) were added as carriers. 
The sample was then applied to Whatman No.3MM paper (30 x 90cm) 
and lOjtl L-cysteine (1mg/mi) and lOjtl L-alanine (1mg/mi) applied Ca. 4 
cm either side of the radioactive sample. The amino acids were separated 
using High Voltage Paper Electrophoresis (3000V, pH2, 30mm). After 
drying, the flanking marker strips were cut from the electrophoretogram, 
wet with ninhydrin (2%w/v) in acetone, dried at 400C and L-cysteine (Rf 
0.25) and L-aianine (Rf 0.45) indentified.. The band corresponding to L-
alanine was cut from the unstained section of the electrophoretogram and 
eluted with 0. 1M ammonia solution. Scintillation fluid (Smi) was added 
to the eluate (ca. imi) and the radioactivity measured. 
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Inactivation of E.coli Cysteine Desuiphurase 
DH1iJpIMSB cell-free extract (imi, 34 mg/ml) was dialysed against lOOmi 
Tris buffer (50mM, pH 7.5) overnight. Aliquots (200ti) were transferred 
to five eppendorfs and L-allylgiycine added to a final concentration of 0, 5, 
10, 20, and 50mM (Final vo1ume=400.t1). The five reaction mixtures were 
incubated at 370C for 2h. The excess L-allyiglycine was removed by 
dialysis with Tris buffer (50mM, p117.5, lOOmi)) for 2h and 100il aliquots 
of each were transferred to five new eppendorfs. 	14C-L-cystine 
(Amersham, 101i1, 0.2,.Ci, ), L-cysteine.HC1 (200DM) and Tris buffer 
(50mM, pH7.5) containing DTT (2mM) were added to a final volume of 
150tl and the reaction mixtures incubated at 370C for 4h. The reaction 
was terminated by boiling for 5min and the precipitated proteins were 
centrifuged (15,000g, 30s). The supernatants were analysed by HYPE as 
described above. 
Purification of E.coli Cysteine Desuiphurase 
DH1iJpIMSB cell-free extract (lOmi, 30mg/mi) was fractionated at ice 
temperature by the addition of solid ammonium sulphate to 20% 
saturation, left to stir for 2h at 40C and then centrifuged (15,000g, 30mm, 
40C). The supernatant was brought to a final concentration of 50% with 
solid (N114)2SO4  at ice temperature, left to stir for 2h at 40C and then 
centrifuged (15,000g, 30mm, 40C). The pellet was resuspended in Tris 
buffer (50mM, pH7.5) (8m1) and dialysed against Tris buffer (50mM, 
p117.5, 250ml) at 40C overnight. The dialysed fraction (3mi, 70mg/mi) 
was loaded onto a DEAE-cellulose anion exchange column (3.5cm x 2 1cm) 
equilibrated with Tris buffer (50mM, pH7.5). The column was washed 
with Tris buffer (50mM, pH 7.5, lOOmi) and the proteins eluted (1.5 
ml/min) with a linear salt gradient (0-750mM NaCl in the same buffer). 
Active fractions were combined and dialysed against Tris buffer (50mM, 
pH 7.5) at 40C overnight. The dialysed sample (imi) was loaded onto a 
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Mono Q Sepharose column (F?Lc) 	 and theproteins eluted 
(imi/min) with a linear salt gradient (0-600mM NaCl in the same buffer). 
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